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1 Summary 
In this study we have investigated the possible role of c-Jun and it’s activation by the 
JNK pathway in neuronal cell death and in the inflammatory response of activated 
astrocytes. The first part of this thesis focuses on the role of site specific 
phosphorylation of c-Jun in neuronal cell death. The second part focuses on the 
function of c-Jun in LPS-mediated activation of Bergmann glia cells. 
In the nervous system, activation of c-Jun transcription factor by different isoforms of 
c-Jun N-terminal kinase (JNK) functions in various cellular programs, including 
neurite outgrowth, repair and apoptosis. Yet, the regulatory mechanism underlying 
the functional dichotomy of c-Jun remains to be elucidated. Serine (S) 63/73 and 
threonine (T) 91/93 of c-Jun are the target phosphorylation sites for JNKs in 
response to various stimuli. Yet, these two groups of phosphorylation sites are 
differentially regulated in vivo, as the S63/73 sites are promptly phosphorylated upon 
JNK activation, whereas T91/93 phosphorylation requires a priming event at the 
adjacent T95 site. In our study, we used cerebellar granule cell (CGC) apoptosis by 
trophic/potassium (TK) deprivation as a model system to investigate the regulation 
and function of site-specific c-Jun phosphorylation at the S63 and T91/T93 JNK-sites 
in neuronal cell death. In this model system, JNK induces pro-apoptotic genes 
through the c-Jun/Ap-1 transcription factor. On the other side, a survival pathway 
initiated by lithium leads to repression of pro-apoptotic c-Jun/Ap-1 target genes 
without interfering with JNK activity. Yet, the mechanism by which lithium inhibits c-
Jun activity remains to be elucidated. We found that TK-deprivation led to c-Jun 
phosphorylation at all three JNK sites. However, immunofluorescence analysis of c-
Jun phosphorylation at single cell level revealed that the S63 site was 
phosphorylated in all c-Jun-expressing cells, whereas the response of T91/T93 
phosphorylation was more sensitive, mirroring the switch-like apoptotic response of 
cerebellar granular cells (CGCs). Furthermore, we observed that lithium impaired c-
Jun phosphorylation at T91/93, without interfering with S63/73 phosphorylation or 
JNK activation, suggesting that T91/T93 phosphorylation triggers c-Jun pro-
apoptotic activity. Notably, expression of a c-Jun mutant lacking the T95-priming site 
for T91/93 phosphorylation (c-Jun A95) mimicked the effect of lithium on both cell 
death and c-Jun site-specific phosphorylation, whereas it was fully able to induce 
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neurite outgrowth in naïve PC12 cells. Vice-versa, a c-Jun mutant bearing aspartate-
substitution of T95 overwhelmed lithium-mediate protection of CGCs from TK-
deprivation, validating that inhibition of T91/T93/T95 phosphorylation underlies the 
effect of lithium on cell death. Mass-spectrometry analysis confirmed that c-Jun is 
phosphorylation at T91/T93/T95 in cells. Moreover, recombinant-JNK 
phosphorylated c-Jun at T91/T93 in a T95-dependent manner. Based on our results, 
we propose that T91/T93/T95 phosphorylation of c-Jun functions as a sensitivity 
amplifier of the JNK cascade, setting the threshold for c-Jun pro-apoptotic activity in 
neuronal cells. 
In the central nervous system (CNS), the c-Jun transcription factor has been mainly 
studied in neuronal cells and coupled to apoptotic and regenerative pathways 
following brain injury. Besides, several studies have shown a transcriptional role of 
c-Jun in activated cortical and spinal astrocytes. In contrast, little is known about c-
Jun expression and activation in Bergmann glial (BG) cells, the radial cerebellar 
astrocytes playing crucial roles in cerebellar development and physiology. In this 
study, we used neuronal/glial cerebellar cultures from neonatal mice to assess 
putative functions of c-Jun in BG cells. By performing double immunocytochemical 
staining of c-Jun and two BG specific markers, S100 and GLAST, we observed that 
c-Jun was highly expressed in radial glial cells derived from Bergmann glia. 
Bergmann glia-derived cells expressed toll-like receptor (TLR 4) and treatment with 
bacterial lipopolysaccharide (Le et al.) induced c-Jun phosphorylation at S63, 
exclusively in BG cells. Moreover, LPS induced IL-1β expression and inhibition of 
JNK activity abolished both c-Jun phosphorylation and the increase of IL-1β mRNA. 
Notably, we also observed that LPS failed to induce IL-1β mRNA in neuronal/glial 
cerebellar cultures generated from conditional knockout mice lacking c-Jun 
expression in the CNS. These results indicate that c-Jun plays a central role in c-Jun 
in astroglial-specific induction of IL-1β. Furthermore, we confirmed in vivo that c-Jun 
is expressed in BG cells, during the formation of the BG monolayer. Altogether, our 
finding underlines a putative role of c-Jun in astroglia-mediated neuroinflammatory 
dysfunctions of the cerebellum. 
Zusammenfassung 
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2 Zusammenfassung 
In dieser Studie wurde die Rolle des Transkriptionsfaktors c-Jun sowie seine 
Aktivierung durch den JNK Signalweg beim neuronalen Zelltod und bei der 
entzündlichen Reaktion von aktivierten Astrozyten untersucht. Der erste Teil dieser 
Arbeit beschäftigt sich mit der Rolle von mehrfacher c-Jun Phosphorylierung an den 
Aminosäuren Threonin 91/93/95 beim neuronalen Zelltod. Der zweite Teil 
konzentriert sich auf die Rolle von c-Jun und seine Transaktivierung in LPS-
vermittelter Aktivierung von Bergmann Gliazellen. 
 
Als Modellsystem für den neuronalen Zelltod wurde die Apoptose von cerebellären 
Granularzellen (CGC) durch trophische  Granulazellen Kaliumkonzentration-
Erniedrigung (TK) verwendet, da es ein Modell der Um das ist, das Zusammenspiel 
von pro-apoptotischen und pro-Überleben Signalwegen beim neuronalen Zelltod zu 
studieren. In diesem Modell induziert die c-Jun N-terminale Kinase (JNK) pro-
apoptotische Gene durch den c-Jun/Ap-1 Transkriptionsfaktor. Auf der anderen 
Seite, führt ein Lithium-induzierter Überleben-Signalweg zur Unterdrückung der pro-
apoptotischen c-Jun/Ap-1 Zielgene, ohne Interferenz mit JNK Aktivität. Es blieb 
jedoch der Mechanismus zu klären, durch den Lithium c-Jun-Aktivität hemmt. In der 
Arbeit wurde dieses Modellsystem benutzt, um die Regulation und Funktion der c-
Jun-Phosphorylierung durch JNK an den Stellen S63 und T91/T93 beim neuronalen 
Zelltod zu studieren. 
 
Es wurde gefunden, dass TK-Kaliumerniedrigung zu c-Jun phosphorylierung führte 
und zwar an allen drei durch JNK phosphorylierbaren Ser/Thr (JNK-Stellen). 
Immunfluoreszenzanalyse von c-Jun Phosphorylierung auf Einzel-Zell-Ebene ergab 
jedoch, dass die S63-Stelle in allen c-Jun-exprimierenden Zellen phosphoryliert 
wurde, während T91/T93 Phosphorylierung empfindlicher war, analog zur Schalter-
ähnlichen apoptotischen Antwort von CGCs. Umgekehrt verhinderte Lithium T91 
und T93 Phosphorylierung und Zelltod ohne Wirkung auf die S63-Seite, was darauf 
hindeutet, dass T91/T93 Phosphorylierung durch c-Jun eine pro-apoptotische 
Aktivität auslöst. 
Dementsprechend schützte eine c-Jun-Mutation, der die T95 Priming-Stelle für 
T91/93 Phosphorylierung fehlt (T95A), CGCs vor Apoptose, wohingegen T95A 
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Neuriten-wachstum in PC12-Zellen induzieren konnte. Umgekehrt führte eine c-Jun 
Mutante mit Aspartat-Substitution von T95 (T95D ) zur Aufhebung der schützenden 
Wirkung von Lithium auf CGC Apoptose, wodurch bestätigt wurde, dass die 
Inhibierung der T91/T93/T95 Phosphorylierung der Wirkung von Lithium auf den 
Zelltod zugrundeliegt. Massenspektrometrie-Analyse bestätigte multiple 
Phosphorylierung von c-Jun an T91/T93/T95 in den Zellen. Außerdem wurde 
rekombinantes c-Jun durch JNK an T91/T93 in einer T95-abhängigen Weise 
phosphoryliert. Basierend auf diesen Ergebnissen wird vorgeschlagen, dass 
T91/T93/T95 phosphorylierung von c-Jun als Empfindlichkeit-Verstärker der JNK-
Kaskade fungiert, der die Schwelle für die pro-apoptotische Aktivität von c-Jun in 
neuronalen Zellen einstellt. 
 
Im zentralen Nervensystem (ZNS) wurde die Rolle des c-Jun Transkriptionsfaktors 
hauptsächlich bei neuronalem Zelltod und bei neuronaler Regeneration nach 
Hirnschädigung untersucht. Außerdem wurde auch eine Rolle für c-Jun bei der 
Transkription in aktivierten kortikalen und spinalen Astrozyten beschrieben. Im 
Gegensatz dazu ist wenig bekannt über die Expression von c-Jun und dessen 
Transaktivierung in Bergmann Gliazellen (BG)-Zellen, die eine entscheidende Rolle 
bei der Entwicklung des Kleinhirns und dessen Physiologie spielen. 
 
In dieser Arbeit wurde die putative Rolle von c-Jun bei kultivierten neuronalen/BG-
Zellen aus dem Maus-Kleinhirn untersucht. Immunfluoreszenzanalyse von c-Jun und 
zwei für BG-Zellen spezifische Marker, S100 und GLAST, ergab, dass c-Jun in BG-
Zellen hoch exprimiert wurde. Außerdem wurde gefunden, dass der Toll-like 
Rezeptor TLR4 in BG-Zellen exprimiert ist und dass die Behandlung mit bakteriellem 
Lipopolysaccharid (Le et al.) die c-Jun- Phosphorylierung an S63 induziert. 
Zusätzlich wurde gefunden, dass LPS IL-1b Expression induziert und die Inhibierung 
von JNK Aktivität verhinderte sowohl c-Jun-Phosphorylierung, als auch die Zunahme 
von IL-1 b mRNA. 
 
Insbesondere konnte LPS die IL-1b mRNA-Produktion in neuronalen / BG-Kulturen 
aus konditionellen Knockout Mäusen, denen c-Jun im ZNS fehlte, nicht induzieren, 
womit gezeigt wurde, dass c-Jun bei der Astroglia-spezifischen Induktion von IL-1 b 
essentiell ist. Immunohistochemische Analyse von c-Jun-exprimierenden Zellen im 
postnatalen Kleinhirn bestätigte in-vivo die Expression von c-Jun in BG Zellen und 
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förderte eine dynamische Expression von c-Jun während der Entwicklung der BG 
Monolayer zutage. Insgesamt unterstreichen die Befunde dieser Arbeit eine 
wahrscheinliche Rolle von c-Jun bei Astroglia-vermittelten neuroinflammatorischen 
Funktionsstörungen des Kleinhirns. 
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3 Introduction 
3.1 AP-1 proteins 
The transcription factor activator protein-1 or AP-1 is composed of a variety of 
dimers which are members of the Jun and Fos families of nuclear factors. 
The Fos proteins (c-Fos, FosB, Fra-1, and Fra-2) do not form homodimers but can 
heterodimerize with members of the Jun family. The Jun proteins (c-Jun, JunB, and 
JunD) can either homodimerize or heterodimerize with other Jun or Fos members. In 
addition to Fos proteins, Jun proteins can also heterodimerize efficiently with other 
transcription factors, such as members of the activator transcription factor (ATF) 
family (ATF2, ATF3 and B-ATF) as well as members of the MAF family (c-Maf, 
MafB, MafA MafG/F/K and Nrl) (Angel & Karin, 1991; Gruda MC, 1994; Chinenov Y, 
2001). All AP-1 members contain a common domain known as basic leucine zipper 
that is necessary to form dimeric complexes and interact with the DNA back bone. 
Initially, AP-1 was found to function in a variety of cellular events involved in normal 
development and neoplastic transformation. Then, genetically modified mice models 
have shown that various AP-1 members function in the control of cell proliferation, 
differentiation and apoptosis. The contribution of cellular functions of AP-1 depends 
on the composition of AP-1 dimeric subunits, the kind of stimulus and cellular 
environment. (Jochum et al., 2001; Mechta-Grigoriou et al., 2001; Shaulian & Karin, 
2002) 
c-Jun, the most studied AP-1 member, can form homodimers and heterodimers with 
either FOS and ATF proteins, JUN-JUN homodimers and JUN-FOS heterodimers 
bind preferentially to the DNA responsive element 5′-TGAG/CTCA-3’, that is named 
12-O-tetradecanoylphorbol-13-acetate (TPA) responsive element (TRE), as it is 
strongly induced by a tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). 
Instead, JUN-ATF heterodimers bind preferentially to the 5′-TGACGTCA-3′ 
sequence, known as cyclic AMP responsive element  (Chinenov Y, 2001; Ambacher 
et al.). In addition to TPA and c-AMP, c-Jun/AP-1 activity is induced by several other 
external cues, including serum (Fig 3.1) (Lamph et al., 1988; Ryder & Nathans, 
1988) growth factors (Quantin & Breathnach, 1988; Ryder & Nathans, 1988; Wu et 
al., 1989), cytokines, neurotransmitters, bacterial and viral infections, a variety of 
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physical and chemical stress (Morton et al., 2003) and oncoproteins, including v-Src 
or Ha-Ras (Angel & Karin, 1991). The Jun protein was originally identified as an 
oncoprotein encoded by a cellular insert in the genome of avian sarcoma virus 17. 
The c-Jun protein is composed of a N-terminal region containing the JNK binding 
domain (JBD), the activation domain having several phosphorylation sites (1–190 
AA),  a hinge region (191– 256AA), a basic, positively charged domain composed of 
18 amino acids (257–276AA), the leucine zipper or dimerisation domain (280–
308AA) and the C-terminal domain. c-Jun transcriptional activity is mainly dependent 
on phosphorylation of it’s N-terminal domain at serine 63 and 73 (S63&73) and 
threonine 91 and 93 (T91&93) residues (Smeal et al., 1991; Morton et al., 2003), as 
well as the dephosphorylation of Thr239 (Papavassiliou et al., 1995; Morton et al., 
2003) and acetylation of lysine residues in the basic domain (Vries et al., 2001). To a 
large extent, c-Jun phosphorylation is under the direct or indirect control of different 
components of the MAPK family of serine and threonine phosphorylation kinases 
include the JNK-1, 2 and 3 (Whitmarsh & Davis*, 2000) Phosphorylation of c-Jun at 
Thr239 and Ser243 by GSK3β function as docking targets for the F-box&WD domain 
repeated 7 (FBW7) ubiquitin ligase, that allows the subsequent degradation of c-Jun. 
Recently, it was found that the c-Jun 5’UTR harbours a potent internal ribosomal 
entry site (Guma et al., 2010) with a virus-like IRES domain that directs cap-
independent translation in glioblastoma cells (Blau et al., 2012). 
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Fig 3.1: The AP-1 transcription factor. AP-1 (activator protein 1) proteins include 
the JUN, FOS, ATF (activating transcription factor) and MAF (musculoaponeurotic 
fibrosarcoma) protein families, which can form homodimers and heterodimers 
through their leucine-zipper domains. The different dimer combinations recognize 
different sequence elements in the promoters and enhancers of target genes A) The 
leucine-zipper domain and the adjacent basic domain form an X-shaped α-helical 
structure in the AP-1 complex, which binds to the DNA backbone B) c-JUN binding 
partners and the corresponding responsive DNA binding elements C) The main DNA 
response-element is the TPA-responsive element (TRE), but different dimmers 
preferentially bind to elements such as the CAMP-RESPONSE ELEMENT 
(Ambacher et al.), the MAF-recognition elements (MAREs) and the antioxidant-
response elements (Barnat et al.). D) c-FOS binding partners and the corresponding 
responsive DNA binding elements. NFIL-6, nuclear factor interleukin-6; NRF, nuclear 
respiratory factor; NRL, neural retina leucine zipper.             
 From: Nat Rev Cancer. 2003 Nov;3(11):859-68 
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3.2 Regulation of c-Jun phosphorylation 
AP-1 activation by JNKs is mainly achieved by phosphorylation of c-Jun N-terminal 
domain (Davis, 2000). c-Jun N-terminal phosphorylation at serine residues 63, 73 
and threonine residues 91, 93 by JNK has shown to induce transcription of several 
AP-1 target genes, one of which is the c-Jun gene itself (Angel et al., 1988). 
Phosphorylation of c-Jun at both S73 and S63 is important for JNK-induced 
biological effects. In fact, replacement of these canonical JNK sites of c-Jun with 
canonical sites for protein kinase A (PKA) phosphorylation abolishes the effect of 
JNK activation on the induction of c-Jun/AP-1 target genes (Smeal et al., 1991). 
Similarly, replacement of S63/S73 of c-Jun with alanine residues (JunAA) prevents 
JNK-mediated (Yang et al., 1997) excitotoxic cell death following exposure to 
kainate (Behrens et al., 1999). 
c-Jun phosphorylation at S63/S73 is induced by a myriad of extracellular signals with 
either transient or prolonged signalling dynamics (Morton et al., 2003; Vinciguerra et 
al., 2004) and it functions in diverse physiological pathways, inducing genes involved 
in cell cycle progression, differentiation and apoptosis (Eferl & Wagner, 2003; 
Hayakawa et al., 2004; Karin & Gallagher, 2005). Differently T91/T93 
phosphorylation by JNK is induced mostly by destructive cues, including genotoxic 
stress and chemotherapeutic drugs (Morton et al., 2003; Vinciguerra et al., 2008; 
Madeo et al., 2010). Moreover, T91/T93 phosphorylation requires a priming event at 
the adjacent T95 (Vinciguerra et al., 2008). Abrogation of this priming site impairs c-
Jun activation and lead to selective inhibition of T91/T93 phosphorylation in 
response to various types of genotoxic stress, including UV radiation and 
anisomycin (Vinciguerra et al., 2008). Importantly, it has previously shown that in 
mammal cells the JNK cascade converts damaging stress stimuli in a sensitive 
switch-like response (Bagowski et al., 2003). Therefore, the differential regulation of 
the S63/S73 sites versus the T91/T93 may reflect a switch-like response of JNK to 
genotoxic cues, with small stimuli rising S63/S73 phosphorylation and larger supra-
threshold stimuli inducing T91/T93 phosphorylation. Until now, the relevance of c-
Jun N-terminal phosphorylation in these processes has been examined only for the 
S63/S73 sites (Watson et al., 1998; Behrens et al., 1999; Besirli et al., 2005). These 
studies have shown that S63/S73 phosphorylation is crucial for exitotoxic neuronal 
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apoptosis. On the other hand, S63/S73 phosphorylation is also involved in neuronal 
differentiation processes, as neurite outgrowth in PC12 cells (Leppa et al., 1998; 
Dragunow et al., 2000) and neurotransmitter specification in early neuronal  
development (Marek et al., 2010). Moreover, S63/S73 phosphorylation is required 
for c-Jun-dependent induction of inflammatory cytokines in immune-regulatory cells, 
including spinal astrocytes and Bergman glial cells. 
The C-terminal region of c-Jun contains two critical phosphorylation sites, Thr239 
and Ser243 which function as docking domain for the F-box&WD domain repeated 7 
(FBW7) ubiquitin ligase. This phosphorylation allows the subsequent degradation of 
c-Jun (Wei et al., 2005). Thr239 residue is phosphorylated by glycogen synthase 
kinase-3 (GSK3) and this phosphorylation event depends on priming 
phosphorylation of Ser243 (Morton et al., 2003). In case of viral c-Jun, the 
phosphorylation of Thr239 is blocked by the substitution of Ser243 with 
phenylalanine, causing the stabilization of viral Jun protein (v-Jun) (Boyle et al., 
1991; Wei et al., 2005). Recently it was been shown that the dual-specificity tyrosine 
phosphorylation–regulated kinase DYRK2 functions as a priming kinase action on c-
Jun (Taira et al., 2012b). Importantly, phosphorylation of c-Jun on both Thr239 and 
Ser243 is required for the FBW7 ubiquitin ligase engagement at c-terminus domain. 
On the other side, the phosphatase causing dephopshorylation of Thr239 and 
thereby giving the stability to c-Jun is yet to be indentified (Fig 3.2). 
The stability of c-Jun protein also depends on N-terminal phosphorylation other than 
C-terminus phosphorylation of c-Jun (Fuchs et al., 1997; Musti et al., 1997). 
Complete abrogation of N-terminal phosphorylation of c-Jun at all four major 
phosphorylation sites, i.e. S63&73 and T91&93, will result in a block of FBW7-
mediated degradation, independently of the Thr239 and Ser243 phosphorylation. 
This gives a hint that N-terminal phosphorylation may act as an alternative 
degradation pathway for preferential removal of the N-terminal activated c-Jun and 
antagonize the apoptotic JNK signaling (Nateri et al., 2004). It is possible that 
differently spliced FBW7 isoforms may select the different phosphorylated (S63-T93 
or Thr239 & Ser243) substrates (Nateri et al., 2004; Wei et al., 2005). 
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Fig 3.2: Overview of diverging c-Jun activation pathways, via JNK, GSK3 and p300. 
The scheme shows the c-Jun structural domains, c-Jun phosphorylation sites and 
kinases that regulate c-Jun phosphorylation. Sharp arrows show activating, and 
blocked arrows the inhibitory effects, stippled arrows – facilitating effects. The N-
terminal and C-terminal ends of c-Jun are marked by N and C, respectively. Ac, 
acetylating; dP, dephosphorylating; and P, phosphorylating effect; DEP, dependent; 
IND, independent; JBD, JNK binding domain; TAD, activation domain; BR, basic 
region; LZ, leucine zipper. 
 
           From: J Neurochem. 2008 Nov;107(4):898-906 
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3.3 Modulators of c-Jun activity 
c-Jun is an immediate early gene whose expression levels increase within an hour of 
exposure to a variety of extracellular stimuli. c-Jun is regulated both at the 
transcriptional and post-translational level (Boyle et al., 1991; Lin et al., 1992), 
(Pulverer et al., 1991; Smeal et al., 1991). Furthermore, same stimuli may induce 
both c-Jun expression and N-terminal phosphorylation (Pulverer et al., 1991; Smeal 
et al., 1991). As previously mentioned, induction of c-Jun transcription by growth 
factors, tumor promoters or genotoxic stress is mediated by two AP-1/ATF like DNA 
binding elements present in the c-Jun proximal promoter. 
3.3.1 Negative modulators of c-Jun and its cellular functions 
1) Ubiquitination: Ubiquitination represents a particular case where ubiquitin 
(Ub),  itself a small polypeptide, is linked to lysine residues in a protein to 
target it for proteasomal degradation (Ciechanover, 1998). It has been 
demonstrated that c-Jun undergoes degradation by ubiquitination. Three 
ubiquitin ligases were reported to induce the ubiquitination and degradation of 
c-Jun. One ligase is the human COP1, which forms a multi-subunit ubiquitin 
ligase complex, DCXhDET1−hCOP1 and promotes c-Jun degradation regardless 
of c-Jun's phosphorylation status (Wertz et al., 2004; Savio et al., 2007; 
Migliorini et al., 2011). A second ligase is Itch, whose E3 ligase activity needs 
to be activated by JNKs through phosphorylation, causing the degradation of 
c-Jun in a manner independent of c-Jun phosphorylation by JNKs (Gao et al., 
2004). The third c-Jun E3 ligase is Fbw7 (also called Fbxw7, CDC4, AGO and 
SEL10; (Nateri et al., 2004) which forms a ligase complex with SKP1 and 
CUL1 that is referred to as SCFFBW7 (Welcker & Clurman, 2008). C-terminal 
phosphorylation of c-Jun at T239 by GSK3β (Wei et al., 2005) is required for 
Fbw7-dependent degradation. In turn, Fbw7 expression and activity impairs 
neuronal apoptosis allowing c-Jun degradation by the ubiquitin/proteasome 
system (Fig 3.3) 
2) Sumoylatoin: Recently, several proteins that share similarity with Ubiquitin 
(Ub) have been identified. One member of this ubiquitin-like protein family is 
SUMO-1, a polypeptide of 101 amino acids which can be attached covalently 
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to proteins in a process that is mechanistically analogous to ubiquitination. It 
has been shown that c-Jun activation may also be regulated by sumoylation. 
Sumoylation of c-Jun has been demonstrated to occur at Lys229 (Müller et 
al., 2000) and at Lys257 (Bossis et al., 2005) Furthermore it has been shown 
that sumoylation negatively regulates the c-Jun transactivity (Cheng et al., 
2005). 
3) DYRK2: Dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) 
constitute an evolutionarily conserved family of protein kinases with key roles 
in the control of cell proliferation and differentiation. Members of the DYRK 
family phosphorylate many substrates, including critical regulators of the cell 
cycle. One characteristic feature of several DYRK kinases is their function as 
priming kinases, meaning that the phosphorylation of a given residue by a 
DYRK is prerequisite for the subsequent phosphorylation of a different 
residue by another protein kinase (GSK3 or PLK). Taira et al. 2012, have 
shown that DYRK2 expression and activity regulates the levels of c-Jun and 
c-Myc degradation at the G1/S boundary. Many tumor cells depend on high 
levels of c-Jun and c-Myc to enter S phase. Cellular levels of these oncogenic 
transcription factors are controlled by proteasomal degradation, which is 
initiated upon phosphorylation by GSK3β. DYRK2 has now been identified as 
the priming kinase for the phosphorylation of c-Jun and c-Myc by GSK3β. In 
particular, DYRK2 phosphorylates c-Jun at  the T242 priming site for GSK3β 
phosphorylation at the T239 site, hence allowing Fbw7-dependent 
degradation of c-Jun (Taira et al., 2012a). 
4) HDACs: HDACs (Histone deacetylases) are catalytic subunits of multiprotein 
complexes that deacetylate specific lysines on tail of histones, as well as 
several other non histone proteins. There is growing evidence for a role of 
HDACs in neuronal survival. Recent studies provided evidence that HDAC7 
and HDAC3-mediated neuroprotection results from inhibition of c-Jun 
expression. HDAC7 inhibits c-Jun transcription by directly associating with c-
Jun on the c-Jun gene promoter. However, repression of c-Jun transcription 
by HDAC7 is relieved by c-Jun N-terminal phosphorylation. Furthermore, 
over-expression of either HDAC3 or HDAC7 impairs cell death of cerebellar 
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granular neurons upon serum/potassium withdrawal (Weiss et al., 2003; Xia 
et al., 2007a; Ma & D'Mello, 2011). 
5) Mkp-1: MAPK phosphatases (Mkp-1) are a family of DUSPs (Dual-specificity 
phosphotases) that inactivate MAP kinases by dephosphorylation. It has been 
shown that MKP-1 represses JNK-mediated apoptosis upon γ-radiation in 
MEFs (Mouse embryonic fibroblasts) (Laderoute et al., 1999). Over 
expression of Mkp-1 in sympathetic neurons prevents c-Jun N-terminal 
phosphorylation and c-Jun expression, hence protecting neurons from NGF 
withdrawal-induced death (Wang et al., 2008; Kristiansen et al., 2010). This 
study demonstrates that NGF withdrawal leads to  JNK-dependent 
phosphorylation of c-Jun and ATF2., hence inducing the expression of c-
Jun/ATF pro-apoptotic target genes, as dp5, bim, and puma. Furthermore, the 
study shows that ATF binds the Mkp1 gene  promoter and increases Mkp1 
expression, hence acting in a negative feedback manner. 
6) Mbd3/NuRD: An important mechanism of AP-1 activation is phosphorylation 
of c-Jun by JNKs. N-terminal phosphorylation of c-Jun activation domain 
causes the transcriptional activation of several target genes, but the 
molecular mechanism of target gene activation is not yet clearly understood. 
Recently, a study by Behrens and collaborators has shown that 
unphosphorylated c-Jun interacts with Mbd3 and thereby recruits the 
nucleosome remodelling and deacetylation complex NuRD  on its target 
genes. However, c-Jun N-terminal phosphorylation counteracts Mbd3/c-Jun 
complex formation, hence resulting in the depression of c-Jun target genes. 
Subsequently, a co-activator protein binds to c-Jun and further augment the 
expression of c-Jun target genes. Interestingly, it has been shown the 
Mbd3/c-Jun complex plays an important role in controlling cellular proliferation 
in  intestinal tumors (Aguilera et al., 2011). 
7) E1A: Adenoviral induced transformation of cells require E1A interaction with 
transcriptional regulators, as the transcriptional co-activators p300, also 
named CREB-binding protein (CBP). E1A and p300/CBP have been shown to 
affect the transcription levels of common genes (Arany et al., 1995). For 
example, the c-Jun promoter is activated independently by either E1A or p300 
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(Monique CA Duyndam, 1999). On the other hand, the collagenase promoter 
is inhibited by E1A, a repression mechanism dependent on the p300/CBP-
binding domain of E1A (Dorsman et al., 1995). The binding of E1A to 
p300/CBP was suggested to be responsible for the effect of E1A on the AP-1 
family of transcription factors (Lee et al., 1996; Smits PH, 1996), including c-
Jun and c-Fos, which play a central role in proliferation and differentiation. So 
far, the mechanism of E1A-mediated repression of the collagenase promoter 
via the c-Jun DBD has been unclear. Similarly, the co-activator CBP/p300 
appears to mediate the transcription regulation of c-Jun by E1A, but the 
mechanism remains unclear. Recently it has been shown that a 12 amino 
acid motif within the basic region of the c-Jun DBD is required for the 
repression of c-Jun expression by E1A. Furthermore, the involvement of p300 
acetyltransferase activity and c-Jun acetylation at Lys271 seem to be involved 
in the  regulation of collagenease gene expression (Vries et al., 2001). 
8) MEKK1: c-Jun activity is regulated by mitogen activated protein kinase (MAP) 
Kinase signaling pathway – MEKK or MKKK – MEK or MKK – MAPK. MEKK1 
phosphorylate several substrates and also acts as a ubiquitin (Ub) E3 ligase 
(Lu et al., 2002). Recent studies have shown that c-Jun is down regulated in 
response to osmotic stress via ubiquitination-dependent degradation, that 
seems to mediated by the PHD/RING finger domain of MEKK1, which has E3 
ubiquitin ligase activity (Lu et al., 2002; Witowsky & Johnson, 2003). MEKK1 
SWIM domain (SWI2/SNF2 and MuDR) represents a novel substrate-binding 
domain necessary for direct interaction between c-Jun and MEKK1 that 
promotes MEKK1-dependent c-Jun ubiquitylation (Rieger et al., 2012). 
Deficiency of MEKK1 has been shown to block posttranslational down 
regulation of c-Jun in response to osmotic stress (Xia et al., 2007b). 
9) C/EBP alpha: The transcription factor C/EBP alpha is important for normal 
myeloid differentiation and inactivation of C/EBP alpha leads to myeloid 
leukemia. It was shown that c-Jun prevents  granulocyte differentiation, as its 
downregulation is necessary for granulocytic lineage commitment. Down 
regulation of c-Jun expression was shown to be mediated by C/EBP alpha by 
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direct interaction with c-Jun, hence abrogating c-Jun binding to its own 
promoter (Rangatia et al., 2002). 
10)  COP1: constitutive photomorphogenesis protein 1 (COP1), a RING finger 
ubiquitin ligase targets P53 for ubiquitin degradation, which impairs upon 
DNA damage and allows the stabilization of P53 (Dornan et al., 2006). It has 
been also shown that COP1 interacts with c-Jun and modulates its activation 
(Bianchi et al., 2003). Recent studies using a transgenic mice expressing a 
COP1 mutant containing a functional E3 ligase RING but lacking the 
interaction domain WD40, confirmed that the Cop1 negatively regulates cell 
proliferation in a c-Jun-dependent manner (Migliorini et al., 2011). 
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Fig 3.3: Schematic of an E 3 SCF (complex of SKP1, CUL1 and F‑box protein) 
ubiquitin ligase. The SKP1 (S-phase kinase-associated protein 1)–CUL1 (cullin 1)– 
RBX1 (RING box 1) core complex recruits substrates (c-Jun) through 
interchangeable substrate-specific F‑box proteins. RBX1 binds to the E2 ubiquitin-
conjugating enzyme (UBC) that was previously charged with ubiquitin (Ub) by an E1 
ubiquitin-activating enzyme (UBA). Polyubiquitylated substrates are then targeted for 
destruction by the proteasome. 
 
           From: Nat Rev Cancer. 2008 Feb;8(2):83-93 
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Table: 
Modulator Mechanism Function 
Ubiquitination 
(Fbw7, COP1, Itch) 
Degrades c-Jun protein upon N-
terminal phosphorylation dependent  
and independent manner 
Cancer, Neuronal 
apoptosis 
Sumoylation Sumo-1 conjugation at Lys 242 and 257 --- 
DYRK Phosphorylation of c-Jun at Thr242 
 
Breast cancer 
HDACs Inhibition of c-Jun expression Neuronal cell death 
MKP-1 Dephosphorylates JNK and intern 
reduce the c-Jun activity 
Neuronal cell death 
MBD3 (NURD) Unphosphorylated form of c-Jun binds 
to mbd3 and recruite NuRD repressor 
complex, which intern releases upon 
phosphorylation of c-Jun 
 
Intestinal tumors 
E1A Acetylation of Lys271 Proliferation and 
Differentiation 
MEKK1 Ubiquitin degradation  Osmotic stress- 
Apoptosis 
C/EBPalpha Represses c-Jun binding on DNA 
promoter 
Granulocyte 
differentiation and 
apoptosis 
Cop1 Reduce the c-Jun activation by 
ubiquitination 
Tumour suppression 
 
Table 3.1: Negative modulators of c-Jun 
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3.3.2 Positive modulators of c-Jun and its cellular functions 
1) CBP/P300: Overexpression of p300 leads to efficient stimulation of ATF2 
activity, a weak stimulation of the c-Jun activity and no significant activation of 
either JunD and ATF3. This study also shows that ATF2 is a specific target of 
p300 and this interaction plays a role in the transactivation of the c-Jun 
promoter. The CREB binding domain of CBP is sufficient to contact to c-Jun 
in vitro. Expression of CBP in vivo stimulates c-Jun dependent transcription. 
Deletion analysis of c-Jun indicates that the CBP binding domain is within the 
N-terminal domain. Alanine substitutions of S63/73 in c-Jun or the 
corresponding residues in v-Jun (Ser36/46) leads to reduced binding to CBP 
in vitro and abolishes augmentation of transcription in vivo. These data are 
consistent with a mechanism by which CBP acts as a co-activator protein for 
c-Jun dependent transcription by interacting with the Jun N-terminal activation 
domain (Arias et al., 1994; Bannister AJ, 1995; Goodman & Smolik, 2000). 
Furthermore, a phosphorylation independent interaction between CBP and c-
Jun was also detected (Lee et al., 1996). 
2) RACO-1: c-Jun is an AP-1 transcription factor known for its role in regulation 
of cell proliferation, apoptosis and tumorigenesis; however the exact 
molecular mechanism linking growth factor signaling to c-Jun/AP-1 activation 
is unclear. Recent studies have shown that RACO-1 (newly identified RING-
domain containing protein) is a c-Jun co-activator, linking growth factor 
signaling to c-Jun/AP-1 activation (Davies et al., 2010; Davies et al., 2013). 
These studies show that RACO-1 interacts with c-Jun and is both necessary 
and sufficient for c-Jun/AP-1 activation. Interestingly, coexpression of a 
constitutively active MEK1 construct, or treatments with the tumour promoter 
12-O-tetradecanoyl phorbol 13-acetate (TPA),  increased RACO-1 protein 
levels, hence linking MEK1 activity with c-Jun/AP-1 activation. Moreover, 
RACO-1 methylation by methyltransferase PRMT1 was shown to induce 
RACO-1 stability and dimerisation, as well as RACO-1/c-Jun interaction 
(Davies et al., 2010; Davies et al., 2013). 
3) TCF4: Nateri et al. have shown that the interaction between TCF4 and c-Jun 
phosphorylated by JNK has an important role in the regulation of intestinal 
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cancer, thus uncovering a link between JNK and canonical Wnt signaling i.e 
ß-catenin independent signaling pathway (Veeman et al., 2003). Wnt 
signaling counteracts ß-catenin degradation, hence allowing ß-catenin to 
accumulate in the nucleus and to induce gene expression by interacting with 
members of the LEF/TCF family of transcription factors (Giles et al., 2003). 
The authors found that N-terminal phosphorylated c-Jun interacts with TCF4 
and in turn forms a ternary complex with ß-catenin. The significance of the c-
Jun–TCF4 interaction in tumorigenesis was investigated in a mouse model of 
intestinal cancer that was originated by crossing mice carrying a 
heterozygous non-sense mutation of the APC gene (ApcMin/+) with JunAA/+ 
mice, carrying alanine substitutions of S63/S73 JNK-phosphorylation  sites . 
The authors found that in the ApcMin/+; JunAA+/+ mice, lack of c-Jun–TCF4 
interaction was associated with an extended lifespan and a reduced  number 
and size of tumors. Furthermore, colon tumor development was prevented in 
ApcMin/+ mice carrying gut-specific knockout of c-Jun. These findings suggest 
that gut specific inhibition of JNK could result in lack of c-Jun/TCF4 
interaction, therefore representing an effective strategy for treatment of 
intestinal tumors (Nateri et al., 2005). 
4) RACK1: The c-Jun transcription factor is a highly unstable oncoprotein. As 
mentioned above several ubiquitin ligases mediate c-Jun degradation. 
However, c-Jun can be stabilized once it is phosphorylated at the N-terminus 
by c-Jun N-terminal kinases (JNKs) or other protein kinases (Musti et al., 
1997). This phosphorylation decreases c-Jun ubiquitination and degradation. 
The underlying mechanism for this phenomenon is still unknown. Recently it 
was shown that the receptor for activated C-kinase 1 (Rack1) can form a 
complex with c-Jun and ubiquitin ligase Fbw7 (Zhang et al., 2012). However, 
this study shows that c-Jun is released from the complex upon its N-terminal 
phosphorylation and cannot be any longer ubiquitinated by Fbw7, suggesting 
a possible mechanism through which N-terminal phosphorylation of c-Jun 
augments c-Jun stability. On the other hand, N-terminal phosphorylated c-Jun 
can still be degraded in shRack1 cells, whereas knockdown of Fbw7 
suppresses degradation of JNK-phosphorylated c-Jun. Hao et al. (Hao et al., 
2007) reported that Fbw7 forms homodimers to efficiently degrade its 
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substrates. Therefore, the speculation is that Rack1, when over-expressed, 
might heterodimerise with Fbw7 through the WD40 interaction domain and 
this might result in more binding to non-phosphorylated c-Jun, but less 
binding to N-terminal phosphorylated c-Jun. In absence of Rack1, Fbw7 
forms homodimers, which bind c-Jun regardless of the phosphorylation status 
at the N-terminus, thereby targeting N terminal phosphorylated c-Jun for 
degradation. (Zhang et al., 2012). 
5) Sp1: Chen et al have demonstrated that c-Jun/Sp1 interaction is essential for 
growth factor- and phorbol 12-myristate 13-acetate (PMA)-induced genes 
expression, including human 12(S)-lipoxygenase, keratin 16, cytosolic 
phospholipase A2, p21(WAF1/CIP1), and neuronal nicotinic acetylcholine 
receptor beta4. They found that PP2B-dependent dephosphorylation of c-Jun 
C-terminus (Ser-243) was required for interaction of c-Jun with Sp1 and for 
the PMA-induced gene regulation (Chen et al., 2007). More recent studies 
have identified that also calcineurin (Hauwel et al.) is involved in the 
dephosphorylation of c-Jun C-terminus at Ser-243, which in turn increases 
the interaction between c-Jun and Sp1 and c-Jun-dependent transcription 
(Huang et al., 2007). 
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Fig 3.4: Schematic representation of a JNK-dependent interaction between c-Jun 
and TCF4/ ß -catenin on the c-Jun promoter. 
                From: Nature. 2005 Sep 8;437(7056):281-5  
 
Table 3.2: 
Modulator Mechanism Function 
 
CBP/P300 
p300/CBP enhances c-Jun 
transcription through two promoter 
elements, Jun1 and Jun2 
 
Tumours 
RACO-1 RACO-1 interact with c-Jun Intestinal tumour 
 
TCF4 
Phosphorylated form of c-Jun binds 
to TCF4 and forms ternary complex 
with ß-catenin 
 
Intestinal cancer 
 
RACK-1 
Rack1 protects the N-terminal 
phosphorylated c-Jun from FBW7-
mediated degradation 
 
Tumorigenesis 
 
Sp1 
dephosphorylation of c-Jun C- 
terminus (Ser-243) was regulated by 
PP2B and required for the c-
Jun/Sp1 interaction 
 
--- 
 
 
Table 3.2: Positive modulators of c-Jun 
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3.4 Role of c-Jun in cellular proliferation 
A role for AP-1 in the control of cell proliferation has been suggested by the following 
observations: (i) mitogens stimulate both AP-1 activity, (Donahue et al.) ii) 
expression of various Fos and Jun proteins  have distinct expression patterns during 
cell cycle progression; (iii) cell cycle progression of fibroblasts can be inhibited by 
intracellular injection of neutralizing antibodies versus various member of AP-1, 
including c-Jun and c-Fos (Angel & Karin, 1991; Kovary & Bravo, 1991b; Kovary & 
Bravo, 1991a). Furthermore, the role of c-Fos and c-Jun in cell cycle progression 
were confirmed by knocking down c-Fos and c-Jun expression in mouse fibroblast 
and erythroleukaemia (Holt et al., 1986; Nishikura & Murray, 1987; Shaulian & Karin, 
2002). In addition, experiments using fibroblasts derived from either c-Fos  or c-Jun 
knockout mice provided genetic support for these conclusions (Brüsselbach S, 1995; 
Brown et al., 1998) (Johnson et al., 1993; Schreiber et al., 1999). Also, Ha-ras 
induced transformation of immortalized mouse fibroblasts requires c-Jun and AP-1 
expression (Johnson et al., 1996). As regard the role of JNK-mediated 
phosphorylation of c-Jun in cell proliferation, fibroblasts from c-Jun Ala 63/73 mice 
have a proliferation defect, indicating that it is important for cell proliferation 
(Behrens et al., 1999). 
c-Jun induction was also shown to be necessary for cell cycle re-entry of fibroblasts 
after genotoxic stress, as c-Jun -/- fibroblasts undergo prolonged growth arrest and 
fail to resume proliferation after UV exposure. By contrast cells with constitutive 
expression of c-Jun fail to arrest and continue to cycle after UV exposure (Shaulian 
et al., 2000). Presumably, c-Jun negatively regulate p53 transcription by directly 
binding the p53 promoter, as p53 is upregulated in c-Jun-/- fibroblasts (Schreiber et 
al., 1999). Furthermore, c-Jun inhibits the expression of the CDK inhibitor p21cip1 
(Shaulian et al., 2000), a p53 gene target gene that is responsible for 
antiproliferative activity of p53 (El-Deiry et al., 1993; Xiong et al., 1993). 
Correspondingly, c-Jun-/- fibroblasts have lower level of G1/CDK activity, due to 
elevated expression of p21cip1 (Schreiber et al., 1999). Hence, it seems that c-Jun 
regulates cell cycle progression through two different mechanisms: (i) induction of 
cyclin D1 transcription, (Donahue et al.) repression of p21cip1expression. Several 
AP-1 proteins, including c-Jun, bind to AP-1 regulatory sequences of cyclinD1 
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(Albanese et al., 1995; Bakiri et al., 2000). In addition, phospho mimicking mutations 
that replace S63 and 73 of c-Jun with negatively charged residues increases the 
extent of cyclinD1 induction by mitogens (Bakiri et al., 2000). By contrast, JunB acts 
as a negative regulator of cell proliferation by repressing cyclinD1 expression and by 
inducing transcription of the p16Inka gene, a CDK inhibitor blocking Rb 
phosphorylation by mitogen (Passegue & Wagner, 2000). 
As regard tumorigenesis, c-Jun has been shown to be important for the development 
of both skin and liver tumours. In fact, expression of a dominant-negative c-Jun 
mutant  (TAM67) in basal keratinocytes and a conditional inactivation of c-Jun in the 
liver, interferes with the development of chemically induced papillomas and liver 
tumours,  respectively (Young et al., 1999; Eferl et al., 2003). Hepatoblasts derived 
from c-Jun-/- foetuses also display proliferation defect and exhibit extensive 
apoptosis of hepatoblasts and hematopoietic cells. More importantly, liver 
regeneration after partial hepatectomy is impaired in absence of c-Jun expression 
(Behrens et al., 1999). 
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3.5 Role of c-Jun in central nervous system 
Induction of c-Jun expression is a common event in the developing, adult as well as 
injured nervous system. In the central nervous system (CNS), c-Jun is highly 
expressed during embryogenesis (Wilkinson et al., 1989; Bennett et al., 1997) and 
through postnatal day 15 (P15) (Mellström et al., 1991), after then expression 
decreases to a lower basal level throughout adulthood (Herdegen et al., 1991; 
Raivich & Behrens, 2006). In the adult brain, c-Jun expression is induced after injury, 
stress (Herdegen & Waetzig, 2001; Raivich et al., 2004), ischemia and stroke 
(Jenkins R, 1991; Wessel et al., 1991), as well as in seizures (Morgan & Curran, 
1989; Gall et al., 1990; Gass et al., 1993). On the other hand, c-Jun is also induced 
during learning and memory (Donahue et al., 2002; Konstantin & Steven, 2006), 
suggesting a functional dichotomy of c-Jun in both injured and unperturbed brain. 
Functional studies employing in vivo strategies for gene deletion, targeted 
expression of dominant negative isoforms and pharmacological inhibitors, all appear 
to confirm a bipotential role of c-Jun  in the brain, with a crucial role in neuronal cell 
death, but also in plasticity and repair (Raivich & Behrens, 2006). However, JNK-
dependent phosphorylation of c-Jun is important for neuronal cell death but not for 
axonal repair, pointing to a complex picture, with only a partial functional overlap 
between Jun and JNK. Therefore, a better understanding of the non overlapping 
roles could considerably increase the potential of pharmacological agents to improve 
neurological outcome during and following brain-damaging conditions; for example 
by a specific blockade of the unfavourable effects of the cascade during the disease 
process (Waetzig & Herdegen, 2004). 
Neuronal apoptosis contributes to the progression of neuropathological disorders 
such as stroke and neurodegenerative disease (Mattson, 2000). JNK-dependent 
activation of c-Jun  has been shown to participate to several neuronal death 
paradigms, including those initiated by beta-amyloid toxicity (Pearson et al., 2006; 
Thakur et al., 2007; Maria B.Fonseca1, 2012)., trophic factor withdrawal (Eilers et 
al., 1998; Le-Niculescu et al., 1999), and ischemia (Kuan et al., 2003). 
Expression of c-Jun is highly induced in response to neuronal injury (Herdegen & 
Leah, 1998). Nerve fiber transection results in a characteristic reaction of the injured 
neuron, the so-called axonal response (also Summary termed cell body response or 
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chromatolytic response) (Schwaiger et al., 1998; Stoll & Müller, 1999; Goldberg, 
2003). On the molecular level, nerve injury results in dramatic changes of the 
transcriptional program of the injured neuron, some of which are mediated by the 
induction of immediate-early transcription factors of the AP-1 family (Herdegen & 
Leah, 1998). How the axonal damage is sensed and converted into a transcriptional 
nuclear response is unclear. JNKs have been suggested to participate in the 
initiation of the axonal response, as they are rapidly activated following nerve injury 
and JNKs can be transported on microtubules along the axon, via their association 
with motor proteins of the kinesin family (Verhey & Rapoport, 2001). Therefore, it 
was earlier suggested that the JNK/c-Jun pathway could function as a sensor and 
trigger the axonal response (Goldstein, 2001). 
3.5.1 Role of c-Jun in neuronal cell death 
Programmed cell death has been implicated in normal development as well as in the 
progression of acute and chronic neurodegenerative events, as stroke, spinal cord 
injury, Alzheimer’s disease, Parkinson’s disease and Huntington’s disease. Several 
kinases have been involved in regulation of neuronal apoptosis, including GSK3 and 
JNK protein kinases families. 
It has been shown that during embryonic development increase of cell death takes 
place in coincidence with higher levels of c-Jun expression (Sun et al., 2005). 
Moreover, it has been found that during brain trauma (Herdegen et al., 1991; 
Jenkins & Hunt, 1991; Raivich et al., 2004), brain ischemia (Jenkins R, 1991; 
Wessel et al., 1991) and seizures (Morgan & Curran, 1989; Gall et al., 1990; Gass et 
al., 1993) c-Jun expression levels are increased. Likewise, c-Jun induction has been 
observed in human neurodegenerative diseases, such as amylotrophic lateral 
sclerosis (MIGHELI et al., 1997) and Alzheimer’s dementia. In the latter disease, 
Amyloid-β (Aβ) incubation of neuronal cells results in stress-induced cell death 
through poorly understood mechanisms (Pearson et al., 2006; Thakur et al., 2007; 
Fonseca et al., 2012). In a model of Parkinson’s disease, where exposure to the 
neurotoxic chemical MPTP causes degeneration of dopaminergic neurons in the 
substantia nigra, (Oo et al., 1999; Saporito et al., 1999; Chen et al., 2012), inhibition 
of JNK/c-Jun pathway reduces MPTP-mediated dopaminergic cell loss (Saporito et 
al., 1999; Xia et al., 2001; Wang et al., 2004) suggesting that targeting of the JNK/c-
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Jun pathway could limit neuronal loss in Parkinson’s disease (Silva et al., 2005; 
Borsello & Forloni, 2007). 
As regard studies in primary neuronal cultures, c-Jun has been shown to induce the 
expression of proapoptoic genes, such as dp5, BIM and PUMA, both in cerebellar 
granular neurons and sympathetic neurons upon potassium deprivation or trophic 
factor deprivation, respectively (Whitfield et al., 2001; Besirli et al., 2005; Ma et al., 
2007; Towers et al., 2009; Kristiansen et al., 2010). In particular, abrogation of c-Jun 
expression in postnatal sympathetic neurons has shown that c-Jun is essential for 
neuronal cell death induced by NGF withdrawal (Palmada et al., 2002). Furthermore, 
studies in a knock-in mouse model, where the endogenous c-Jun wt gene was 
replaced by a c-Jun mutant containing alanine substitution of S63-73 (cJunA63-73 
mice) (Behrens et al., 1999) have shown that c-Jun phosphorylation at S63/S73 
sites is important for cell death by neurotrophic factor deprivation. c-Jun has also 
been show to be phosphorylated at S63/73 in several other models of neuronal 
death, including apoptosis of embryonic motoneurons (Sun et al., 2005), cerebellar 
granule neurons deprived of survival signals(Watson et al., 1998), or in trophic 
factors-deprived sympathetic neurons (Eilers et al., 2001; Xu et al., 2001). 
Altogether, these studies suggest that the JNK/c-Jun signaling cascade may be 
important for developmental neuronal death occurring during the competition of 
neurons for neurotrophic factors in short supply (Fig 3.5). 
Neuronal cell death also increases during inappropriate axonal response to 
peripheral nerve injury, as failure of axons to reinnervate their target may result in 
neuronal death, due to lack of trophic support from the peripheral axonal 
compartment (Sendtner et al., 1996). Interestingly, brain-specific ablation of c-Jun 
inhibits axon regeneration and muscle reinnervation; however it also prevents 
axotomy-induced cell death (Raivich et al., 2004). These observations suggest that 
neurotrophic factors may selectively inhibit the pro-apoptotic function of c-Jun during 
axonal regeneration. Intriguingly, in a different study, motoneurons from c-JunA63-
73 mice were not significantly protected from axotomy-induced cell death (Behrens 
et al., 1999). This observation raises the question whether signaling pathways 
regulating c-Jun phosphorylation at T91/T93 are activated in this context. However, 
so far suitable genetic models to study this aspect of c-Jun activation are missing. 
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Concerning pathological neuronal cell death, c-Jun phosphorylation at S63-73 is 
crucial for apoptosis following glutamate neurotoxicity or CNS injury. Primary 
cortical/hippocampus neurons from cJunA63-73 mice are protected from kainate-
induced exitotoxicity (Behrens et al., 1999). Similarly, dopaminergic neurons from c-
JunA63-73 mice survive after exposure to radical stress, or transsection of the 
medial forebrain bundle (Brecht et al., 2005). Conversely, JNK-dependent 
phosphorylation of c-Jun on S63-73 triggers axotomy-induced apoptosis of 
dopaminergic neurons (Crocker et al., 2001), or apoptosis of retinal ganglion cells by 
optic nerve transection (Lingor et al., 2005). 
As mentioned above, the functional impact and the regulation of c-Jun 
phosphorylation at T91-T93 during neuronal death has not been yet elucidated. 
However, T91/T93 phosphorylation is as important as that of S63-73 for JNK-
mediated activation of c-Jun by a variety of stress-signals (Morton et al., 2003; 
Weiss et al., 2003; Vinciguerra et al., 2008). Moreover, the extent of JNK-dependent 
phosphorylation of T91-93 and c-Jun activation is tightly dependent on a preceding 
phosphorylation at the ATM/ATR site T95, suggesting that the integration of different 
signal-induced pathways is important to activate c-Jun in response to stress 
(Vinciguerra et al., 2008). In view of these observations, it is important to determine 
which specific pattern of c-Jun N-terminal phosphorylation is present during different 
examples of neuronal cell death; as well as to investigate whether and how signaling 
pathways leading to T91-93 and T95 phosphorylations control c-Jun-mediated 
neurite outgrowth or c-Jun-mediated cell death, in the context of neuronal injury and 
regeneration. 
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Fig 3.5: Hypothetical model showing the role of the MLK-JNK-c-Jun pathway in 
trophic factor induced cell death. After NGF or potassium withdrawal, JNK activation 
leads to phosphorylation of the AP-1 transcription factors c-Jun and ATF2, hence 
increasing the expression of AP-1 target genes. c-Jun binds to ATF binding sites 
present in the promoters of c-Jun itself (the Jun1 and Jun2 TREs) to enhance its 
own transcription in a positive feedback manner. c-Jun/Ap-1 also binds to AP-1 sites 
present in the promoter of pro-apoptotic genes, such as dp5, bim, and puma, as well 
as to ATF binding sites present in the mkp1 promoter. This leads to increased 
expression of Mkp1, which in turn can dephosphorylate JNKs in a negative feedback 
manner. 
 
            From: The Journal of Neuroscience, August 11, 2010 • 30(32):10820 –10832 
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3.5.2 Role of c-Jun in neuronal regeneration 
The complexity of polarized neurons needs extremely challenging intracellular 
signaling pathways to maintain the polarity with defined axonal and dendritic 
extensions. Following injury, axons of mammalian CNS (Central nervous system) 
(Tom et al., 2004)  do not regenerate, whereas those of PNS do (Peripheral nervous 
system) (Ertürk et al., 2007). The inability of CNS neurons to regenerate their axons 
reflects both intrinsic properties of axons and the presence of an inhibitory CNS 
environment. Upon axonal injury, two phases of regenerative responses takes place: 
I) rapid and local modifications, as local translation of several proteins involved in the 
cytoskeleton function (Ex: Importin, vemintin, dynin, actin, GTPases and kinases) 
(Willis et al., 2005) II) activation of different signaling proteins (Ex: STAT3 and JNK 
phosphorylation) at injury sites. These events cause cytoskeleton modifications 
promoting growth cone formation and axonal out growth (Sheu et al., 2000; 
Charlotta Lindwall, 2012). At later stages, injury signals reach the cell body via 
retrograde signaling and turn on either regenerative programs or cell death 
programs (Shin et al., 2012). 
Analysis of c-Jun conditional knock out in CNS has shown no phenotypical changes 
and mice lacking c-Junf in neural cells (c-JunΔn) were born with Mendelian frequency 
and were viable and fertile (Raivich et al., 2004). C-JunΔn mice lacked neuronal c-
Jun immunoreactivity but showed normal brain histology and normal expression of 
neural markers such as NeuN, MAP-2, neurofilament, synaptophysin, and GFAP. 
However, by using a well described experimental model of facial nerve transection, 
Raivich and collaborators have shown that c-JunΔn mice had significantly diminished 
whisker hair motor neurons performance compared to control mice (c-Junf ) at both 4 
and 15 weeks following facial nerve transection (Raivich et al., 2004). After 
transection of the facial nerve, the absence of c-Jun caused severe defects in 
several aspects of the axonal response, including perineuronal sprouting, 
lymphocyte recruitment, and microglial activation. c-Jun-deficient motorneurons 
were atrophic, resistant to axotomy-induced cell death, and showed reduced target 
muscle reinnervation. Furthermore, the axotomized facial motoneurons from c-JunΔn 
mice showed a strong failure in upregulating the expression of galanin, α7β1 integrin 
and CD44, suggesting that these molecules  are crucial for c-Jun-dependent axonal 
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outgrowth. Importantly, the promoters of both galanin and CD44 genes contain AP-1 
sites, which were shown to be functional target site for c-Jun-mediated 
transactivation (Lee et al., 1993; Anouar et al., 1999). 
Activation of both JNK and c-Jun has been also observed in the nuclei of adult rat 
NG (Nodose ganglia) and DRG (dorsal root ganglia) sensory neurons, following 
axotomy of the vagus and sciatic nerve, respectively. Using retrograde tracing, it 
was shown that p-c-Jun and ATF3 were present in regenerative DRG sensory 
neurons. Furthermore, inhibition of c-Jun activation by two different types of JNK 
inhibitors prevented axonal outgrowth in NG and DRG sensory neurons. These 
results indicate that c-Jun activation is associated with axonal outgrowth (Lindwall & 
Kanje, 2005). Similarly, Trent A. Watkins et al (Watkins et al., 2013) have 
demonstrated that disruption of either DLK (an upstream regulator of c-Jun) or c-Jun 
strongly reduces axon re-growth in optic nerve crush, suggesting that the DLK/c-Jun 
axis is necessary for axonal regrowth upon optic nerve crush. 
The striking regenerative capacity of the PNS depends on the surprising plasticity of 
Schwann cells, capable of switching between differentiation states (Jessen & Mirsky, 
2005; Jessen & Mirsky, 2008; Jopling et al., 2011). Schwann cells are principal glia 
of pheripheral nervous system (PNS). They mainly function to support the 
conduction of nervous impulses along axons, nerve development and regeneration 
Glial cells function to support neurons and are involved in important aspects of 
peripheral nerve biology – the conduction of nervous impulses along axons, nerve 
development and regeneration, trophic support for neurons and so on. Schwann cell 
dedifferentiation takes place when cells lose contact with injured axons. This 
represents a beneficial injury response in the distal stump of cut nerves, as 
denervated and dedifferentiated cells promote axon regrowth and nerve repair. The 
instability of myelin differentiation can however also be harmful, as evidenced in 
demyelinating neuropathies, where metabolic disturbances, immune assault, or 
genetic abnormalities lead to debilitating dedifferentiation and loss of myelin. 
Dedifferentiated Schwann cells can readily redifferentiate and myelinate axons if 
conditions are appropriate. Therefore, these cells can potentially choose between 
two states throughout life: the myelinated state or the immature/denervated state. 
Exciting progress has also been made in identifying a group of cell-intrinsic factors in 
Introduction 
 32 
Schwann cells, including the transcription factors Krox-20 (Egr-2), Sox-10, Oct-6 
(SCIP, Tst-1, POU3fl) and NFκB, which act as positive regulators of myelination. 
Negative transcriptional regulators of myelin differentiation are transcription factors 
c-Jun, Sox-2, Pax-3, Krox-24 (Egr-1, NGF1A/zif268), and Egr-3. In particular, c-Jun 
is expressed in immature Schwann cells and is repressed by Krox-20, which is 
essential for myelination. Also, c-Jun blocks myelination in neuron–Schwann cell co-
cultures, it opposes the function of Krox-20 and cAMP-related myelin signals, and 
drives the dedifferentiation of early myelinating cells back to the immature Schwann 
cell phenotype (Fig 3.6) (Parkinson et al., 2004). 
Recently, Peter J et al (rthur-Farraj et al., 2012) clearly demonstrated that c-Jun 
activation in Schwann cells is a global regulator of Wallerian degeneration. c-Jun 
governs major aspects of the injury response, as the expression of trophic factors, 
adhesion molecules, the formation of regeneration tracks and myelin clearance. A 
key function of c-Jun is the activation of a repair program aiming to maintain the 
dediffentiated Schwann cell phenotype. Conversely, c-Jun depletion results in the 
formation of a dysfunctional repair cell, striking failure of functional recovery and 
neuronal death (rthur-Farraj et al., 2012). 
A different study (Fontana et al., 2012) investigated the molecular mechanism by 
which c-Jun controls the ability of Schwann cells to support motoneuron survival and 
axonal regeneration after peripheral nerve injury. This study demonstrates that c-Jun 
is required for the expression of neurotrophin genes like Artn, BDNF-1, GDNF, LIF, 
and NGF purely depends on the expression of c-Jun. Abrogation of c-Jun 
expression leads to down regulation of these neurtrophin causing a poor functional 
recovery of neurons (facial nerve) and a poor survival of motoneurons. They also 
found that cell-specific inactivation of the Ret gene in neurons resulted in 
regeneration defects, without affecting motoneuron survival. Conversely, 
administration of recombinant GDNF and Artemin protein substantially ameliorated 
impaired regeneration caused by c-Jun deficiency. 
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Fig 3.6: A model of the transcriptional regulation of myelination. The myelination 
status of Schwann cells can be viewed as being determined by the balance between 
opposing signaling systems. Positive regulators (green) dominate in normal nerves, 
while the balance shifts to negative regulators (orange) in injured and pathological 
nerves. During development, negative regulators may also take part in timing the 
onset and rate of myelination. In vivo evidence for the negative regulators shown 
only exists for c-Jun and Notch at present, while the molecular identity of the positive 
regulators is better established. 
            From: Glia. 2008 Nov 1;56(14):1552-65 
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3.5.2 Role of c-Jun in neuronal Inflammation 
Several studies have shown a crucial role of the JNK/c-Jun pathway in the 
expression of inflammatory cytokines in activated immune-regulatory cells of the 
cerebrum and spinal astrocytes (Waetzig et al., 2005; Raivich, 2008; Haeusgen et 
al., 2009). In contrast, little is known about the expression and activation of c-Jun in 
Bergmann glial (BG) cells, the radial unipolar astrocytes playing important roles in 
cerebellar development and physiology (Yamada & Watanabe, 2002). BG cells 
develop from radial glial cells in the ventricular zone and then their somata migrate 
towards the Purkinje cells layer (PCL) in synchrony with Purkinje cells. In the mouse 
cerebellum, migration of BG somata starts at embryonic day 14 and ends at 
postnatal day (P) 7, when they align next to the PCs and establish a monolayer 
emitting radial fibers to the pial surface (Yamada et al., 2000). During postnatal 
development of the cerebellum, Bergmann glia provides a scaffold for the migration 
of newly generated granule cells (GC) (Rakic, 1971; Hatten & Mason, 1990). 
Moreover, BG cells establish functional interactions with Purkinje cells and have 
been shown to regulate dendritic arborisation and synaptogenesis of these neurons 
(Yamada & Watanabe, 2002). Like other astrocytes, Bergmann glial cells respond to 
neuronal damage with morphological and functional changes, hence becoming 
reactive or activated glial cells (Furuoka et al.; Lafarga et al., 1991; Lafarga et al., 
1998). 
In vivo, BG gliosis has been associated to loss of Purkinje cells in several examples 
of cerebellar dysfunctions (Duchala et al., 2004; Liu et al., 2005; Ishida et al., 2007; 
Weimer et al., 2009). However, molecules and pathways participating to pro-
inflammatory functions of BG cells have been poorly elucidated. Neuronal/glial 
cerebellar cultures from neonatal mice have been widely used to study the response 
of glial cells to different stimuli (Sass et al., 2001; Ejarque-Ortiz et al., 2007)Previous 
studies have shown that upon treatments with bacterial LPS, a potent activator of 
glial cells, these cultures express pro-inflammatory cytokines. However, the exact 
signaling pathway and glial cell types involved in cytokine induction have not been 
yet determined. We have used this type of cell cerebellar culture to assess putative 
functions of c-Jun in activated Bergmann glial cells. We found that c-Jun is highly 
expressed in the nucleus of radial astrocytes derived from Bergmann glia and its 
activation by JNK is required for the induction of IL-1 expression in response to 
bacterial LPS (Albanito et al., 2011). 
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4 Materials and Methods 
4.1 Device manufacturer 
SDS polyacrylamide gel electrophoresis Mini Protean Tetra Cell 
BioRad, Munich, Germany 
Semi-dry western blot chamber Trans-blot SD, Semi-dry transfer cell 
BioRad, Munich, Germany 
Power supplies Standard Power Pack P25 
Powerpac HC 250V 3A 300W 
BioRad, Munich, Germany 
Centrifuges Centrifuge 5417R 
Centrifuge 5804R 
Centrifuge 5810R 
Eppendorf, Hamburg, Germany 
Heat block Thermomixer 5437 
Thermomixer comfort 
Eppendorf, Hamburg, Germany 
Thermocycler personal 
Thermocycler gradient 
Eppendorf, Hamburg, Germany 
Horizontal agarose gel PEQLAB Biotech. GMBH 
electrophoresis chamber Erlangen, Germany 
Cryostat Modell CM 1950, Leica, Wetzlar, Germany 
Confocal microscope FluoView FV1000, Olympus, Hamburg 
TCS SP2, Leica, Wetzlar, Germany 
X-ray developer X-Omat 2000, Stuttgart, Germany 
Tissue homogenizer for RNA POLYTRON PT2100 
Photometer BioPhotometer 
Eppendorf, Hamburg, Germany 
Tissue sonication for protein lysates UP50H - Compact Lab Homogenizer 
Nanodrop-Spektrophotometer PEQLAB Biotech. GMBH 
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4.2 Materials 
4.2.1 Laboratory animals 
All used mouse lines were housed in the central animal facilities of the University of 
Wuerzburg. The animal care and ethic committees of our institutions approved all 
described procedures and experiments. C57Bl/6 mice were used for generation of 
cerebellar granule cells cultures. Mice carrying a floxed c-Jun allele (c-Jun fl) 
(Behrens et al., 2002), were kindly provided by Dr. Axel Behrens from Cancer 
Research UK.  c-Jun fl/fl were crossed with mice expressing Cre recombinase 
beneath the control of Nestin promoter (Tronche et al., 1999) and crossed again to 
generate c-Jun fl\fl-nestin-Cre+ mice (c-Jun Dn), in which both c-Jun alleles are 
inactivated in cells derived from embryonic neuroepithelium, resulting in CNS-
specific inactivation of c-Jun fl, as previously described (Raivich et al., 2004). 
4.2.2 Cell lines 
1. HEK293T cells 
2. HELA cells 
3. PC12 
4. NSC34 cells 
4.2.3 Chemicals 
Unless mentioned all the chemicals used in this study were of analytical grade and 
purchased from the following companies: Applichem, Amersham, Calbiochem, 
Chemicon, Fluka, Fermentas, Merck, Invitrogen, Sigma and Roth 
4.2.4 Cell culture 
 Components for cerebellar granular neuron 
Bergmann Glia and Microglia                         Source/ Company 
Neurobasal Medium                                              Invitrogen 
Glutamax                                                     GIBCO 
Hank’s Balanced Salt Solution (HBSS)      PAA 
Horse Serum                                              Linaris 
B-27 Supplement                           GIBCO 
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Laminin                                         Invitrogen 
Trypsin (1%)       Worthington 
Trypsin Inhibitor (1%)      Sigma 
Poly-D-Ornithine      Sigma 
1X Phosphate Buffer Saline (PBS)    PAA 
0.075M Potassium chloride    Sigma 
AraC (Cytosine-1-β-D-arabinofuranoside)   Sigma 
DNase I        Sigma 
LPS (Lipopoly Sacharide)     
 Components for lentivirus production source/company 
OptiMEM       Invitrogen 
DMEM (high glucose) +HEPES   Invitrogen 
MEM       Invitrogen 
Fetal Calf Serum     Linaris 
Penicillin / Streptomycin    Invitrogen 
DMSO       Sigma 
Lipofectamine2000     Invitrogen 
Glutamax     Life Technologies 
Geneticin.(G418)     Invitrogen 
 Components for 4% paraformaldehyde solution (4% PFA) 
1.6g PFA 
20ml Distilled water 
3 dry pellets of NaOH 
Warmed in 60°C water bath till PFA is dissolved. 
16.4 ml Na2HPO4 (0.2 M) 
3.6 ml NaH2PO4 (0.2M) 
pH 7.1 – 7.4 
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 Preparation of Mowiol® 4-88 mounting agent. (Polysciences 
Europe GmbH) 
1. Mix using a magnetic stirrer, 4.8g Mowiol® 4-88 and 12g glycerol 
(100ml beaker) 
2. Add 12ml ddH2O and continue stirring till a clear solution is formed at 
room temperature.(at least 4 hrs) 
3. Add 24ml 0.2 M Tris HCl (ph 8.5). Continue stirring. Heat occasionally 
to 50°c in a water bath (10 min). 
Continue stirring until Mowiol is dissolved. 
4. Spin down the solution at 500 x g for 15 minutes to get a clear 
solution at the top. 
5. Preserve the supernatant and store aliquots at -20°c 
4.2.5 Buffers and solutions 
 10mM Tris EDTA buffer (TE buffer) (1L) 
o 10ml 1M Tris-HCl (pH 8.0) 
o 2 ml 500 mM EDTA (pH 8.0) 
 Mouse tail lysis buffer: 
o 0.1M Tris-HCl (pH 8.5) 
o 5mM EDTA (pH 8.0) 
o 0.2% SDS 
o 200mM NaCl 
 Annealing buffer: 
o 100mM K-acetate 
o 30mM HEPES-KOH pH 7.4 
o 2mM Mg-acetate 
 Qiagen buffer 1 
o 50 mM Tris HCl pH 8.0 
o 10 mM EDTA 
o 100 ug/ml RNase A 
o Stored at 2-8C after addition of RNase A 
 Qiagen buffer 2 
o 200 nM NaOH 
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o 1% SDS 
 Qiagen buffer 3 
o 3 M Potassium acetate, pH 5.5 
 SOC medium 
o SOB medium 
o 20g tryptone 
o 5g yeast extract 
o 0.58g NaCl 
o 0.19g KCl 
o 4ml 1M NaOH 
o dd H2O to 1 litre and autoclave. Just before use add: 5ml 2M MgCl2 / L 
o For SOC 20 mM of filter sterile glucose is added to SOB 
 RIPA 
o Tris-HCl: 50 mM, pH 7.4 
o NP-40: 1% 
o Na-deoxycholate: 0.25% 
o NaCl: 150 mM 
o EDTA: 1 mM 
 Lysis buffer I 
o 20mM tris PH 8.0 
o 20% glycerol 
o 1mM EDTA 
o 5mM MgCl2 
o 0.1M NaCl 
o 5mM DTT 
o protease inhibitor 
 Refolding buffer 
o 50mM Tris PH 8.0 
o 1.0 M L-Arginin 
o 0.5mM EDTA 
o 5mM glutathione oxidised 
o 2mM glutathione reduced and protease inhibitor 
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 Dialysis Buffer 
o 20mMTris 
o 0.1mM EDTA 
o 10% Glycerol 
o 150mM NaCl 
4.2.6 Kits 
 1st strand cDNA synthesis kit for RT-PCR (AMV) Roche 
 NucleoSpin_ Plasmid Machery & Nagel 
 Big-Dye Terminator Mix Applied Biosystems 
 QIAquick® gen Gel Extraction Kit Qiagen 
 QIAquick® PCR Purification Kit Qiagen 
 Endofree® Plasmid Maxi kit Qiagen 
 mouse IL-1β ELISA kit (Pierce/Thermo scientific) 
 Pierce GST Spin purification Kit (Thermo scientific) 
 In Situ Cell Death Detection Kit- TMR red- Roche 
 RNeasy Mini Qiagen Kit (Qiagen) 
4.2.7 Plasmids 
Clone Name Vector backbone Source 
pGEX (GST-cJun wt) pGEX-4T1  (Vinciguerra et al 2008)- Self 
cloned 
pGEX (GST-cJun A95) pGEX-4T1  (Vinciguerra et al 2008)- Self 
cloned 
pGEX (GST-cJun A63/73) pGEX-4T1  (Vinciguerra et al 2008)- Self 
cloned 
FUWG (c-Jun wt-HA) Fu_eGFP_TrkB Self cloned in this work 
FUWG (c-Jun A95-HA) Fu_eGFP_TrkB Self cloned in this work 
FUWG (c-Jun D95-HA) Fu_eGFP_TrkB Self cloned in this work 
FUWG (c-Jun A63/73-HA) Fu_eGFP_TrkB Self cloned in this work 
FUWG (c-Jun Panala-HA) Fu_eGFP_TrkB Self cloned in this work 
Table 4.1: List of Plasmids Used 
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4.2.8 Antibodies for Immunocytochemistry 
Primary Antibodies 
Antibody Company Source Dilution 
Pax2 Abnova anti mouse 1:50 (IHC) 
GLAST Millipore anti guinea pig 1:100 (IHC) 
anti-GFP Abcam anti Chicken  1:1000 (IHC) 
c-Jun total  Cellsignalling Anti rabit 1:1000 (Westernblot) 
1:100(IHC) 
c-Jun ser63 Cell Signalling Anti rabit 1:1000 (Westernblot) 
1:200 (IHC) 
c-Jun Thr91 Cell signalling Anti rabit 1:1000 (Westernblot) 
1:200 (IHC) 
S100 Sigma Anti mouse 1:100 (IHC) 
GFAP Sigma Anti mouse 1:2000 (IHC) 
Calbindin Sigma-Aldrich Anit mouse 1:2000 (IHC) 
NeuroD1 Abcam Anti mouse 1:2000 (IHC) 
NeuN Millipore Anti mouse 1:2000 (IHC) 
Pax6    
TLR4/MD2 BioScience Anti mouse 1:100 (IHC) 
CD11b eBioscience Anti rat 1:100 (IHC) 
HAtag Biovision Anti mouse 1:500 (IHC) 
1:1000 (Westernblot) 
JNK/SAPK Cell signalling Anti rabit 1:1000 (Westernblot) 
MCM7 Santacruz Anti mouse 1:1000 (Westernblot) 
Tuj1 Neuromics Anti mouse 1:1000 (IHC) 
Tub a BioScience Anti mouse 1:500 (IHC) 
Neurofilament Abcam Anti Rabit 1:1000(IHC) 
 
Table 4.2: List of primary antibodies used 
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Secondary antibodies 
Antibody Host species Company Dilution 
Cy5 goatanti- mouse 
IgG mouse 
Jackson 1/800-1/1600 (IHC) 
Cy 3 Goat Anti- Rabbit 
IgG (H+L) Rabbit 
Jackson 1/350 (IHC) 
DyLight488 goatanti- rabbit IgG 
Rabbit 
Jackson 1/800 (IHC) 
Alexa 488 Goat Anti- Rabit 
IgG Rabbit 
Jackson 1/5000 
 
Table 4.3: List of secondary antibodies used 
4.2.9 Oligonucleotide sequences 
 Forward- 5’ to 3’ Reverse- 5’ to 3’ 
Actin  GTGGGCCGCCCTAGGCAC 
CAG 
TCTTTAATGTCACGCACGATTTC 
ccl2 AGCACCAGCCAACTCTCACT GGGCGTTAACTGCATCTGGC 
IL- 1β TGAAGGGCTGCTTCCAAACC AGCTTCTCCACAGCCACAAT 
IL-18 ACAACTTTGGCCGACTTCAC GGGTTCACTGGCACTTTGA 
c-Jun loxp CTCATACCAGTTCGCACAGG
CGGC 
CCGCTAGCACTCACGTTGGTAG
GC 
c-Jun Flox CTCATACCAGTTCGCACAGG
CG 
CAGGGCGTTGTGTCACTGAGCT 
IL-1 CTAGGCCACAGAATTGAAAG
ATCT 
GTAGGTGGAAATTCTAGCATCAT
CC 
GST-c Jun CGCGGATCCATGACTGCA 
AAGATG 
CCGGAGCTCTGGGTTGAAGTT 
GCT 
FUGW Jun GGATCCATGACTGCAAGATG
G 
GCGGCCGCTTATCATCTAGAC 
Table 4.4: List of primers used 
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4.3 Methods 
4.3.1 Animals 
All used mouse lines were housed in the central animal facilities of the University of 
Wuerzburg. The animal care and ethic committees of our institutions approved all 
described procedures and experiments. C57Bl/6 mice were used for generation of 
cerebellar granule cells cultures. Mice carrying a floxed c-Jun allele (c-Jun fl) 
(Behrens et al., 1999), were kindly provided by Dr. Axel Behrens from Cancer 
Research UK. c-Jun fl/fl were crossed with mice expressing Cre-recombinase 
beneath the control of Nestin promoter (Tronche et al., 1999) and crossed again to 
generate c-Jun fl\fl-nestin-Cre+ mice (c-Jun Dn), in which both c-Jun alleles are 
inactivated in cells derived from embryonic neuroepithelium, resulting in CNS-
specific inactivation of c-Jun fl, as previously described (Raivich et al., 2004). 
4.3.2 Cell culture 
4.3.2.a Cultures of cerebellar granular neurons 
Cerebellar granule cell cultures were generated from either C57Bl/6 P7 mice as 
previously described (Albanito et al., 2011). Briefly, mice were deeply anesthetized 
and injected with saline solution to remove the blood. After the removal of meninges 
and choroid plexus, cerebella were trypsinized with BME media containing 1% 
trypsin and DNase I (2mg/ml) for 15 min at 370C and then triturated in HBSS 
containing 10 U/mL DNAse I (Roche Diagnostics). Cells were centrifuged at 2,000 
rpm for 7 min and resuspended in BME (Sigma) containing 4 mM glutamine, 10% 
fetal bovine serum, 100 U/mL Penicillin/streptomycin, and 25 mM KCl (Sigma-
Aldrich). After counting, cells were plated on pre-coated Poly-DL-ornithine 
hydrobromide (PORN- Sigma) glass coverslips (3.5 X 106) or six-well multiwell 
plates (5 X 106 density). Cultures were maintained at 37oC, 5% CO2, and media 
were changed every 2 days. After 24 hrs in culture treat the cells with Ara-C for 1 
day (Cytosine-1-%-D-arabinofuranoside) to remove proliferating and non neuronal 
cells. All experiments were performed 6 days after plating (DIV6). For serum 
potassium withdrawal experiments cells where treated with either 5mM KCl (LK) or 
with 25mM KCl (HK) for 4hrs to check phosphorylation levels on western blot or treat 
for 18hrs for apoptotic assays. 
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4.3.2.b Generation of cerebellar neuronal/glial primary culture 
Neuronal/Glial primary cultures were isolated from dissociated cerebellum of 4 day 
old C57Bl/6 pups. Mice were anesthetized and injected with saline to remove blood 
and meninges and choroid plexus were removed. Cerebellum was kept in Hank’s 
BSS containing trypsin-DNase and incubated at 370C water bath for 10min. 
Cerebellum was swirled gently every 5 minutes and washed 3 times with HBSS, 
then triturated the cerebellum in 5ml of BME medium containing DNase and tissue 
was dissociated by pipetting up and down for ten times from top and ten times by 
pressing the pipette tip more firmly against bottom of the tube. Now centrifuge the 
cells at 2000g for 5min at 40C. Supernatant was removed and resuspended the 
granular cells in BME medium containing 10%FCS, 25mM Kcl, 100U/ml penicillin 
and streptomycin and cells were plated in 10cm petridish for 20min to attach the 
Bergmann glial cells to bottom, and remaining cells which are floating were 
decanted. After counting, cells were placed on Poly D,L-ornithin precoated cover 
slips at 7x10p5 density or six well plate at 8x10p5 density. 
4.3.2.c  Cultures of cerebral microglial cells 
Microglial cultures were made from C57Bl/6 P4 mice as previously described 
(Polazzi & Contestabile, 2006). Briefly, brain tissue was cleaned from meninges, 
trypsinized for 15 min and, after mechanical dissociation cell suspension, was 
washed and plated on poly-L-lysine (Sigma) coated (10 Ag/mL) flasks (75 cm2). 
Mixed glial cells were cultured in BME (Sigma) supplemented as described above. 
After 12 days, microglial cells were harvested from the mixed primary glial cultures 
by mild shaking (200 RPM for 2 h) and collected by centrifugation. After counting, 
cells were plated as described above. 
 
4.3.2.d PC12 cell culture 
PC12 cell line was cultured on poly-D-lysine coated dishes in media containing 
DMEM (Invitrogen Ltd.) supplemented with 10% horse serum, 5% FCS, 2mM 
glutamine and penicillin/streptomycin. Cells were grown at 37oC in 5% CO2. For 
neurite outgrowth, cells were plated at a density of 1X106 cells per 9 cm dish. Once 
cells were at 60-70% confluent PC12 cells were treated with 50 ng/ml of NGF and 
maintained for 3 days. PC12 transfections with DNA constructs expressing c-Jun 
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proteins were performed by using Lipofectamin 2000 reagent (Invitrogen) following 
manufacture instructions. After transfections, cells were cultured in absence of NGF 
for 72 hours, then were fixed and processed for immunofluorescensce analysis. 
4.3.2.e Cell death and survival assay 
Cell death of CGCs was assessed by examining nuclear morphology following DAPI 
(4′,6′-diamidino-2-phenylindole hydrochloride) staining as previously described 
(Morrison et al., 2006). Briefly, DAPI stain (0.5µg/ml) was added directly to PBS or to 
secondary antibody and incubated for 20 minutes at room temperature. Cells were 
visualized by fluorescence microscopy (SP2 Leica fluorescent microscope). A 
minimum of 1000 cells were analyzed per treatment. To confirm that condensed 
nuclei indeed denotes apoptotic cell, we co-stained the DAPI with TUNEL staining 
(In Situ Cell Death Detection Kit- TMR red- Roche) according to manufacturer’s 
protocol. It is worth noting that in our experimental settings 100% of TUNEL-positive 
cells were stained as condensed nuclei by DAPI, indicating that this is a valuable 
assay to measure cell death (see Fig: 6.1). 
4.3.2.f Immunocytochemistry 
DIV6 cerebellar granule cultures and PC12 cells were permeabilized with a blocking 
solution containing 0.3% TritonX-100, 10% Goat serum, 0.1% BSA in TBS for 2 hrs 
at room temperature. Then, cells were incubated over night at 4°C with the following 
primary antibodies: anti-rabbit c-Jun (Cell Signalling 1:200), anti-rabbit phospho-c-
Jun-Ser63 (Cell Signalling 1:200), anti-rabbit phospho-c-Jun-Thr91 (Cell Signalling 
1:200), anti-rabbit phospho-c-Jun-Thr93 (Cell Signalling 1:200); or Anti-mouse HA-
tag (Biovision), anti anti-mouse NFL (eBioscience). After removing primary 
antibodies, cells were washed three times (10 min each) with TBS and then 
incubated in permeabilization solution with Alexa-Fluor-conjugated secondary 
antibodies for 2 hrs at room temperature. Cells were then treated with DAPI for 10 
min to stain the nuclei (Sigma-Aldrich 1:8,000). Finally, cells were washed three 
times with TBS for 10 min and one time with PBS and mounted by using Mowiol 
(Sigma-Aldrich). Pictures were taken with the SP2 confocal microscope from Leica. 
Configurations of c-Jun N-terminal phosphorylation were analysed by 
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immunocytochemistry 4 hours after treatments by using site-specific c-Jun 
antibodies recognizing c-Jun when phosphorylated at either S63 or at T91/T93. 
4.3.2.g Immunohistochemistry 
Perfusion of mice: Clean the mice with 70% ethanol, cut open the abdomen skin to 
expose abdominal aorta and vena cava. Insert needle in left ventricle and cut 
immediately the vena cava with forceps. Start perfusion with 4% PFA for 10-15 min 
to get perfect perfusion. Once perfusion is done remove the cerebellum from brain 
and leave it in 4% PFA for 2hrs. Wash the tissue with 1XPBS and start hydration by 
using 10% sucrose leave it for some time. Add drops of 30% sucrose in to tissue 
containing 10%sucrose and leave for some time until tissue dip in the solution. 
Change the sucrose solution with fresh 30% sucrose and leave the tissue for 
overnight in 40C. Now place the dehydrated tissue on to tissue base mold. Cover 
entire tissue block with cryo-embedding media (tissue teck). Slowly place the base 
mold containing the tissue block into liquid nitrogen till the entire block is submerged 
into liquid nitrogen to get tissue frozen completely. Store the tissue block in -800C 
until ready for sectioning. Transfer the frozen tissue on to cryotome cryostat (-200C) 
prior to section. Section the frozen tissue into 30μm thickness using cryotome and 
place the sections on to glass slides. Dry the tissue sections for overnight in room 
temperature. For immunostaining of the sections mark the tissue with PapPen. Block 
the slide sections with blocking solution for 1hr. After one hour add the primary 
antibody (dilute in blocking solution) to the section and leave it for overnight in 40C. 
Next day wash the slide with PBS+0.3% TTX for three times for 5min each. Add the 
secondary antibody (dilute in blocking solution) to slide, leave for two hours at room 
temperature. Wash the slide again with PBS+0.3% TTX for three times for 5min 
each. Mount the slide with cover slip by using aqua poly/mount. 
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4.3.3 Molecular Biology techniques 
4.3.3.a Cloning 
1. Restriction enzyme digestion and analysis of DNA fragment 
Cloning was done using standard laboratory manual of Sambrook et al. For 
restriction digestion of plasmids for cloning, 2.0μg DNA was used with 2-5units of 
restriction enzyme and appropriate buffer depending on the restriction enzyme used. 
The reaction volume was 50μl. For the cloning of PCR products, the entire volume of 
the PCR (50μl) was purified using PCR purification kit (Qiagen) and used for the 
restriction digestion. The reaction was incubated at 37°C for 2-6 hours and analyzed 
by gel electrophoresis on 0.8% to 2% agarose gel in 1XTAE buffer depending on the 
size of the expected DNA fragment to be analyzed using UV detector. 
2. Polymerase chain reaction (PCR) 
DNA vectors expressing HA-tagged human c-Jun proteins were used as templates 
to amplify c-Jun coding regions that were subsequently cloned into the FUGW vector 
(Lois et al., 2002) through the BamHI–NotI digestion.(Vinciguerra et al., 2008) The 
following primers were used for c-Jun sequence amplification: forward 5‘-GGA TCC 
ATG ACT GCA AGA TGG 3’ and reverse 5‘GCG GCC GCT TAT CAT CTA GAC3. A 
standard PCR reaction was done as followed: 25ng DNA,1.5μl each of forward and 
reverse primer (10pmole), 5μl 3prime PCR buffer, 1μl eppendorf triple master mix 
proof reading DNA polymerase, 1μl 10mM dNTPs and made up the volume to 50μl 
with H2O 
cycle conditions:  
Denaturation   5 min 95°C 
Melting conditions   30 sec 95°C 
Annealing conditions  30 sec primer specific  35x 
Extension condition   2.5 min 72°C 
10 min 68°C 
hold     15-22°C 
The amplified product was analysed by gel electrophoresis and nanodrop was used 
for measuring the concentration of the DNA.  
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3. Ligation of restriction enzyme digested DNA 
The vector backbone and the insert are analysed on agarose gel and the 
concentration of the DNA is estimated with the help of the marker. Around 25ng of 
vector was used and 125ng of insert was used for the ligation reaction. 
 
Vector DNA    25ng 
Insert DNA    125ng 
T4-DNA-ligase   1μl 
10x ligase buffer   2μl 
Filled up to a total volume of 20μl with water 
 
At the same time a parallel control only containing vector DNA and no insert is 
performed to test the vector religation. The reactions were incubated overnight at 
16°C. 
4. Transformation of chemical competent E.coli 
Thaw the BL21 competent cells or TOP10 chemically competent E.coli cells on ice. 
Approximately 7µl (50ng) Ligation mixture containing circular DNA was added to 
competent cells and incubated on ice for 30 minutes. Subsequently the 
transformation mixture was heat shocked in 42°C water-bath for 90secound. The 
mixture was kept on ice for two minutes to reduce damage to BL21 cells. Add 1ml 
L.B (With no antibiotic) medium or SOC medium to transformation mixture. The 
Tubes were incubated at 37°C for one hour. 10% of transformed cultures were 
streaked on to LB agar plates with appropriate antibiotic. The agar plates were then 
incubated at 37°C for overnight. For analysis of positive clones single colonies were 
picked up from agar plates and inoculated in 5ml of LB medium containing 
appropriate antibiotic and grown the cells at 37°C for overnight. Next day plasmid 
DNA was extracted from these cultures by using alkaline lysis method. 
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5. Isolation of DNA 
200ml LB medium containing appropriate antibiotic was inoculated with the positive 
clone and Endofree maxi kit (Qiagen) was used to isolate DNA suitable for 
transfection. In general, the bacterial cells were grown overnight at 37oC in a shaker 
incubator. The bacterial pellet was obtained by centrifuging the bacteria at 6000rpm 
for 20min. the medium was removed and the pellet was subjected to alkali lysis 
method of DNA isolation by resuspending in buffer P1 containing RNAse to which, 
10ml of lysis buffer P2was added and gently mixed by inverting the tube up and 
down several times to lyse the bacterial cells. The reaction was neutralized by 
neutralization buffer P3 to precipitate the protein. The supernatant was passed 
through cartage to clear the solution. 2.5ml of buffer EB was added to the solution 
and incubated for 30min of ice to make it endotoxin free. The DNA was column 
purified and then precipitated with isopropanol. The DNA was pelleted by 
centrifuging at 15000rpm at 4oC for 30min. The DNA pellet was washed with 70% 
endofree ethanol, air dried and dissolved in 100μl of endofree TE buffer. The 
concentration and purity was determined using the nanodrop device by checking the 
OD at 260 and measuring the OD260/280 ratio respectively. 
6. Sequencing of the DNA 
DNA sequencing was performed by Sanger sequencing (Sanger et al., 1977) using 
terminator dye (Applied Biosystems). This causes the four used dideoxynucleotides 
(ddNTP), lacking the 3´-OH group to get incorporated and labelled with a different 
fluorescent dye. The fragments of the PCR reaction thus generated are of various 
lengths depending upon the incorporation of the dideoxynucleotides. These 
fragments are separated by size by capillary electrophoresis. At the end the 
sequence is identified by scanning the fluorescent signals of chains separated by 
size. The sequencing was done by following protocol: 
PCR reaction:  
DNA       500ng 
Termination-mix     2μl 
5x sequencing buffer    4μl 
Primer      15pmol 
Fill up to a total volume of 20μl with HPLC water 
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Cycle conditions:  
10 sec   96°C 
4 min    60°C   25X 
5 min    60°C 
hold    22°C 
 
The PCR product was precipitated by adding 50μl of 100% ethanol and 2μl of 3M 
sodium acetate. The DNA was pelleted by centrifugation at 14000rpm for 20min at 
4°C. the pellet was washes twice with 70% ethanol, air dried and dissolved in 20μl of 
Hi-Di formamide and used for sequencing capillary loading. 
4.3.3.b Production of lentiviral particles 
A HIV based lentiviral expression system has been used in this study. The Δ8.9 and 
VSVG vectors were used as helper plasmid for packaging FuVal expression vector. 
HEK293T cells were used for packaging. The cells were propagated in DEMEM + 
10%FCS in 3, 125 cm flasks up to 90% confluence. On the day of packaging, 
following reaction was set up in two 50ml reaction tubes: 
 
Protocol for 6 Plates 
Day1: 
Tube 1     Tube 2 
 
Opti-MEM   9ml         Opti-MEM        9ml 
D8.9    45.0µg        Lipofectamin 2000       216µl 
VSVG    30.0µg 
Expression plasmid  18.0µg 
 
Transfection: 
The above both reaction mixes were incubated for 5min in Room temperature. 
Mixed the both reaction and incubated in room temp for 30min  
Splitting cells: 
The cells were washed with 10ml PBS and the cells were harvested by trypsinization 
with 0.1% trypsin and incubated the cells for 10 min at 37oC and then centrifuged at 
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14000 rpm for 5 min and the pelleted cells were resuspended in 30ml optimem with 
10%FCS. This was then mixed with the transfection mix making the volume to 48ml. 
this was then distributed in 6, 10cm petridishes with 8ml each and incubated in the 
cell culture incubator over night. 
Day2: Washing and media change 
The cells were washed with PBS and the medium was changed to Neurobasal with 
1%glutamax and 2%B27 packaging medium 12 ml in each petridish and were 
incubated for 48hours. The transfection efficiency was estimated by microscopic 
examination. 
Day 3: check the cells for cell growth and transfection rate by observing 
fluorescence. 
Day 4: 
Viral Harvesting 
Two SW28 ultracentrifuge tubes and rotor buckets were sterilized with 70% ethanol. 
Pre-cool the ultracentrifuge to 40C. Supernatant from 10cm dishes collected in 50ml 
falcons and centrifuged at 3,600 rpm for 15min at room temperature in standard cell 
culture centrifuge. During the run, prepare Millex HV 0.45 filters and 50ml syringes.  
Few drops of PBS were added to filters to prewet. Supernatant from 50ml falcons 
were filtered. Filled each SW28 tubes with filtered supernatant, and underlayed the 
tubes with 4ml of 20% sterile sucrose. Tubes were equilibrated to same level with 
TBS-5 buffer. Falcons were centrifuged for 2hrs at 25,000 rpm at 40C. Supernatants 
were removed by suction and don’t disturb the pellet (appears like an opaque spot) 
at bottom of tube. Immediately 100µl of ice-cold TBS-5 buffer was added to each 
pellet, tube were covered with parafilm and kept on Ice and placed the ice box in 
refrigerator at least for 3hrs or overnight. 
 
Re-suspension of viral pellets 
Pellets were dissociated in 100µl TBS-5 buffer by gently pipetting up and down 
without air bubbles and aliquot the re-suspended viral supernatant in -800C. 
4.3.3.c Isolation of total RNA 
Isolation of total RNA by RNeasy Mini Qiagen protocol: 
Cultured cells were Washed in ice cold PBS. Added 200µl of RLT buffer to each well 
and scraped the cells and collected in 1.5ml eppendorf. Lysate is passed through a 
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20-gauge needle attached to sterile plastic syringe at least 10times or until a 
homogeneous lysate is achieved. Equal volume of 70% ethanol has been added to 
homogenized lysate and mixed well with pipett. Up to 700µl of sample has been 
added to RNeasy spin column and placed in 2ml collecting eppendorf. Centrifuged 
the column for 15sec at 10,000rpm and discarded the flow through. 700µl of RW1 
buffer added to RNeasy spin column and centrifuged at 10,000rpm for 15sec. Flow 
through was discarded. Next added 500µl of RPE buffer to column, spin at 10,000 
rpm for 2minuts. Discarded the flow through and eluted the RNA by adding 50µl of 
RNase free H20 and centrifuge at 10,000 rpm for 1minut. 
4.3.3.d Reverse transcriptase polymerase chain reaction 
The total RNA isolated by using the qiagen kit was used as the starting material to 
prepare cDNA by the enzyme reverse transcriptase. This cDNA was used as a 
template for conducting the PCR reactions by using gene specific primers. For the 
synthesis of cDNA and the subsequent PCR reactions, the RT-PCR kit from 
Invitrogen, namely, SuperScript™ III First-Strand Synthesis was used. The 
procedures involving the preparation of cDNA from the total RNA are summarized in 
tabular formats presented below. 
 
Denaturation:                    RNA+Primer (R) + dNTPs (10μl) 
              650C for 15min 
               Place on ice for at least 1min 
 
 
Annealing            Gene specific primer (10pm) + 10X RT Buffer 1μl + 25mM Mgcl2 
4μl + 0.1 M DTT 2 μl + Superscript III RT 1μl 
 
cDNA Synthesis                           50 0C for 50min 
 
 
Terminate Reaction                      850C for 5min 
 
 
Remove RNA                      Add 1μl RNase H 370C for 20min 
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4.3.3.e Quantitative realtime PCR 
Total RNA has been isolated according to RNeasy mini kit protocol (Quiagen). After 
extraction, RNA was treated with RNAse free DNAse (Promega) for 30 min at 370C. 
The cDNA synthesis was done according to the protocol using the SuperScript 
Strand cDNA Synthesis kit (Invitrogen). Then, cDNA was diluted five fold in PCR-
grade water and amplified with gene-specific oligonucleotide primers by using 
LightCycler DNA Master SYBR Green I Kit (Roche) on light cycler 1.5 according to 
manufacturer’s instructions. Melting curve analysis was performed to ensure specific 
PCR product while excluding primer dimers. For each sample, relative levels of 
target gene transcript were calculated as the ratio of Ct value of target gene to that 
of GAPDH. 
4.3.3.f Genotyping of c-Jun Knock out mice 
The head from E14 embryos were put in 300μl lysis buffer and 20μl Proteinase K 
(20mg/ml). 
Incubate head samples at 600C for overnight in a thermomixer. Isolate DNA from 
the dissolved head. 
Add 450μl of 5%SDS and 150μl 3M NaCl and vortex. Add 750μl Chloroform and 
vortex and centrifuge at 40C for 10min at 14000rpm. 
Take the upper phase in a 2ml reaction tube and add 750μl Chloroform and vortex 
and centrifuge at 40C for 10min at 14000rpm. 
Take upper phase in a 1.5ml reaction tube (approximately 600-650μl) add 100% 
ethanol to a final volume of 1ml. 
Mix and centrifuge at 40C for 10min at 14000rpm. 
Wash with 500μl 70% ethanol and centrifuge at 40C for 10min at 14000rpm. 
Dry the pellet and dissolve in 100μl of TE buffer for over night. Use this as DNA 
sample for the PCR. 
Reaction Conditions: following reaction was set up for the genotyping with the help 
of PCR amplification. Standard PCR reaction was set up to make 50μl reaction 
volume with 1 μl DNA, 5 μl 10 x PCR buffer,1 μl dNTP (10 mM), 1 μl each forward 
and reverse primer (10pmol/μl) with 0.3μl Taq polymerase (5-prime) and make up 
the volume to 50μl with H2O. 
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Denaturation   3 min 95°C 
Melting conditions   30 sec 95°C 
Annealing conditions  30 sec primer specific  35x 
Extension condition   30 sec 72°C 
10 min 72°C 
hold     15-22°C 
The product size for the genotyping is 600bp for c-Jun-/-; and 300bp & 350bp for c-
Jun+/- 
4.3.3.g Southern blot 
Digest 10μg genomic DNA in 100μl total volume with 3 units of BamHI restriction 
enzyme per μg DNA at 370C for 6hrs. Add 6x DNA loading buffer to digested DNA. 
Agarose gel electrophoresis: 
0.8% of agarose gel was made and submerged gel in 1X TAE buffer with 0.5μg/ml of 
ethidium bromide. Loaded the samples with HindIII lambda marker. Electrophores at 
25 Volts, 35mAmp for overnight (12-16hrs). Photograph with fluorescent ruler 
 
Protein transfer: 
Soak the gel in 0.2N HCl until the dye front turns into yellow or keep it for 20min. 
Now wash the gel with water. Denature the gel by soaking in at least two gel volume 
of 0.5 N NaOH + 1.5M NaCl solution for 15min twice. Wash the gel again with water. 
Now soak the gel in 1M tris base + 3M NaCl (PH 7.4) solution for 30min twice. Soak 
the gel and nylon membrane in 6X SSC for 10min. Now set up transfer in large 
electrophoresis tray: Fill the transfer buffer (12xSSC) into the two side trays. Place 
the following items (gel sized, saturated with transfer buffer) on the middle support. 
All air bubbles should be carefully removed by rolling with glass pippett. 
o Wick (3mm paper), this should be same width as gel and long enough 
to dip into well which contain transfer buffer. 
o 3 pieces of Whatmann 3mm paper 
o Gel (Upside down) 
o Nylon membrane  
o 3 pieces of Watmann 3mm paper 
o Dry 5cm stack of paper towel (Bunch) 
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o Glass plate with Weight (1.0K.g) 
Surround the gel with plastic wrap or parafilm to prevent the paper towels to come in 
contact with the wet paper below the gel. Prevent evaporation of transfer solution by 
sealing with plastic wrap or parafilm on either end of the tray. Let the transfer for 
overnight. 
Next day, take the blotting material and mark the position of the wells with pencil. 
Dry the membrane at 850C for 1hr. Place the dry membrane on paper towel and 
immobilize the DNA by UV cross linking (100mJ/cm2, push ‘optimal cross- linking’). 
Prehybridisation (2hrs): 
Place the membrane in hybridization bottle with 20ml (min. 100μl/cm2) of 
prehybridization buffer. Incubate at 630C for 2hrs 
Prehybridization Buffer (20ml): 
 
Reagent              Final conc. Volume     mass 
Deionized formamide        50%     10ml 
20X SSPE                   6x      6ml 
50x Denhardt’s reagent          5x        2ml 
20% SDS stick solution            0.5%    500μl 
Salmon Testes DNA (sigma D-9156)   100μg/ml 
10.4mg/ml, boil 5min before use 
dH20 add to 20ml          1.3ml  
 
Radioactive labelling of probe: 
Amplify your PCR product from DNA (probe) and purify the PCR product with PCR 
purification kit. Label 50ng PCR probe with 32P using the Prime It® Random primer 
labelling Kit (Stratagene 300385). 
Supplies & Equipment: 
o Primer It® random Primer Labelling Kit 
o Water bath 370C 
o Water bath 1000C 
o Microfuge 
Reagents: 
o Random 9mer primers or specific primers from PCR or sequencing reaction 
(10ng/μl) 
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o (A-32P) dCTP  
o dNTPs (single tube in powder form) 
o Exo Klenow fragment of DNA polymerase I (4u/μl) 
o Stop mix 
Procedure: 
Following things add to bottom of microfuge tube containing dNTPs: 
50ng of PCR template (1.5μl) 
dH20 – 40.5μl 
Boil the reaction tube in water bath for 5min, centrifuge briefly at room temperature 
to collect condensed liquid from cap of tube. 
Add 5μl isotope dCTP (4u/μl) and 3μl of polymerase mix well and incubate reaction 
at 370C for 5-10min. Stop the reaction by adding 2μl of stop solution. Purify the 
probe with either one of following kits: 
 Nuc Trap probe purification push columns (Strategene 400701), for DNA or    
RNA probe 17bp – 5 kb 
 Qiaquick PCR purification Kit (Qiagen 2804) for DNA probes 100bp – 10kb 
Now count the radioactivity of probe. Take 1μl probe, dilute with appropriate amount 
of scintillation fluid, and use same amount of scintillation fluid as negative control 
count. You should have 1-5x 106 cpm per ml hybridization reaction. Denature the 
probe by boiling for 5min and chill on ice immediately before use. 
Hybridization: 
Add denatured probe to pre-hybridization solution and incubate overnight at 630C in 
hybridization oven. 
Washing (at 650C): 
Wash hybridized membrane with 2x SSC+0.1% SDS for 10min. Again was with 
same buffer for 30min. Then wash membrane with 0.2x SSC+0.1% SDS for 30min 
and repeat this for two times. 
Detection: 
Wrap moist blots in plastic wrap prior to autoradiography. Expose to X-ray film with 
an intensifying screen at room temperature for 48hrs. 
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4.3.4 Protein biochemistry 
4.3.4.a Purification of recombinant protein 
1. Inoculation 
Primary inoculation was done in 5ml L.B medium & grown the culture at 370C for 
overnight. 1ml of primary inoculum was added to 500ml of T.B medium containing 
ampicillin. Cultures were grown 370C until O.D reaches 0.5. Cultures were induced 
with 0.5mM IPTG for 3hrs at 370C. Cultures were centrifuged at 8000rpm for 15min 
to collect the bacterial pellet. 
2. Cell lyses 
Pellet  was suspended in 10ml of lysis Buffer I (20mM tris PH 8.0, 20% glycerol, 
1mM EDTA, 5mM MgCl2, 0.1M NaCl, 5mM DTT & protease inhibitor). Pellet was 
sonicated three times for 30sec each. Lysozyme (50mg/ml) was added to the pellet 
and incubated for 30min at room temperature and centrifuged at 12000 rpm for 
25min. Pellet was resuspended in 10ml lyses buffer I and added 0.5% TTX. Pellet 
was sonicated twice for 30sec and centrifuged at 12000rpm for 25min. Pellet was 
resuspended in 10ml of buffer I and sonicate twice for 30sec and centrifuge at 
12000rpm. 
3. Solubilisation of Inclusion body 
Dissolve the pellet in 10ml Buffer II (20mM Tris PH 8.0, 0.1mM EDTA, 5mM DTT 
and 6M guanidium hydrochloride and add protease inhibitor before use). Stir the 
pellet for 2hrs to overnight in 40C till pellet dissolve. Aliquot the dissolved pellet and 
store at 800C for further use  
4. Refolding of protein 
Add 2ml of dissolved inclusion body to 20- 25ml of refolding buffer (50mM Tris PH 
8.0, 1.0 M L-Arginin, 0.5mM EDTA, 5mM glutathione oxidised, 2mM glutathione 
reduced and protease inhibitor). Leave the protein sample at 40C for 3 days. Take 
the protein sample and dialyse against 20mMTris, 0.1mM EDTA, 10% Glycerol and 
150mM NaCl for overnight at 40C. Aliquot the protein and store at 800C for further 
assays. 
5. Pierce GST spin purification 
Remove bottom tab from the Pierce Glutathione spin column by gently twisting. 
Place the column into centrifuge and centrifuge at 700g for 2min to remove storage 
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buffer. Equilibrate the column with two resin bed volumes of Equilibration/Wash 
buffer. Allow buffer to enter the resin bed and centrifuge at 700xg for 2min to remove 
buffer. Add 500µl of prepared protein (dissolved and dialysed) to column and for 
maximal binding incubate the column at 40C for 30-60min on an end-over-end 
rocking platform. Centrifuge the column at 700g for 2min and collect the flow through 
for analysis. Now wash the resin with two bed volumes of wash buffer for 3times and 
centrifuge at 700g for 2min. Now elute the GST tagged protein from resin by adding 
one resin bed volume of elution buffer. Now centrifuge the column at 700g for 2 
minutes and collect the eluted protein. Repeat the step for three times. 
4.3.4.b In Vitro kinase assay 
Kinase assays were performed by using purified GST-c-Jun proteins as substrates 
(1 µg) and either active recombinant JNK1 (Millipore, 20 ng/20µl reaction) or GSK3 β 
(Biovision, 5ng/20µl). Assays were performed in a total volume of 20µl, containing 1x 
kinase buffer (50 mM HEPES [pH 7.4], 1 mM MgCl2, 20 mM beta-glycerophosphate, 
1 mM Na3VO4, 0.2 mM dithiothreitol [DTT], 1µM pepstatin A, 1 mM PMSF, Protease 
inhibitor and 10mM ATP). Reactions were stopped by the addition of SDS sample 
buffer (100 mM Tris [pH 6.8], 2% SDS, 10% glycerol, 5% beta-mercaptoethanol, and 
0.25% bromophenol blue). Phosphorylation of GST-c-Jun proteins were analysed by 
western blot analysis using either pS63 or the pT91/93 phospho-specific c-Jun 
antibodies described above. 
Kinase assays were also performed by using either c-Jun-Ha immunocomplexes or 
recombinant FL c-Jun protein (200ng, Enzo life sciences) and either active 
recombinant JNK1 (Millipore, 20 ng/20µl reaction) or GSK3 β (Biovision, 5ng/20µl). 
Assays were performed in a total volume of 20µl, containing 1x kinase buffer (50 mM 
HEPES [pH 7.4], 1 mM MgCl2, 20 mM beta-glycerophosphate, 1 mM Na3VO4, 0.2 
mM dithiothreitol [DTT], 1µM pepstatin A, 1 mM PMSF, Protease inhibitor and 10mM 
ATP). Reactions were stopped by the addition of SDS sample buffer (100 mM Tris 
[pH 6.8], 2% SDS, 10% glycerol, 5% beta-mercaptoethanol, and 0.25% bromphenol 
blue). Phosphorylation of c-Jun proteins were analysed by western blot analysis 
using either pS63 or the pT91/93 phospho-specific c-Jun antibodies described 
above. 
 
4.3.4.c Immunoprecipitation 
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HEK 293T or NSC-34 cells were plated at density of 5million (5x106) cells per 10cm 
dish and 18 hours later were transfected by using Lipofectamin 2000 reagent 
(Invitrogen) with FUGW-c-Jun constructs. 48 hours later total proteins extracted with 
RIPA buffer as previously described . Primary antibodies, either anti-rabbit c-Jun 
antibodies (Cell Signalling 9165) or sepharose-conjugated mouse HA antibodies 
(Covance clone 16B12 monoclonal) were added to total cell extracts and incubated 
overnight at 4°C. Immuno-precipitated proteins complexes were collected 
(Vinciguerra et al., 2008)d by using Protein A–agarose beads (Roche) previously 
washed with PBS and equilibrated with RIPA buffer. After 1 hour incubation, pellets 
were collected by centrifugation at 1,000 g, and beads were washed three times with 
RIPA buffer. For in vitro phosphorylation assays, immunocomplexes were 
equilibrated in kinase buffer. 
4.3.4.d Western blot 
Total lysates were prepared from cerebellar primary cultures by using 1x Laemmli 
buffer (100mM Tris-HCl, pH6.8, 2% w/v SDS, 20% v/v glycerol, 4% v/v β-
mercaptoethanol) and then heating at 100 C for 10  min. The samples were then 
cooled for 10 min on ice and collected by centrifugation at 14000 rpm for 15 minutes. 
Proteins were electrophoresed under reducing condition on 10% polyacrilamide gel 
and transferred onto Hybond C nitrocellulose membrane (Amersham). The 
membranes were first incubated overnight at 4°C with a rabbit anti c-Jun (Cell 
Signalling 1:1000), anti rabbit phospho-c-Jun Ser63 (Cell Signaling1:1000) and 
MCM7 (Santa Cruz 1:2000). Blots were then incubated with peroxidase-linked anti-
rabbit (1:6,000, Pierce) or anti-mouse (1:6,000, Chemicon) IgG conjugates for 1 hour 
at room temperature. Signals were detected with the ECL system (Amersham 
Biosciences). 
4.3.4.e Luciferase assay 
For luciferase assays, CGCs were plated into 24-well plates with 500 μl of regular 
growth medium/well and at DIV5 were transfected using calcium phosphate method 
as previously described (33). In brief, transfection-solutions contained 87.6 μl of 
HBS- Hepes-buffer saline and 4.4 μl of 2.5 M calcium chloride with 1.0 µg of either 
c-Jun-Wt or c-Jun-A95, 250ng of Jun2 Luc and 20ng of Renilla plasmids. 35 μl of 
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transfection solutions was added to a total of 500 μl of HBSS and added to cells. 
Precipitation was allowed for 50 min. Then cells were washed with HBSS medium 
twice and incubated with condition medium. Luciferase activity was then measured 
using the Dual Luciferase Kit (Promega) according to the manufacturer’s 
recommendations. Firefly luciferase activity was normalized to the internal 
transfection control provided by the Renilla luciferase activity. The normalized 
relative light unit values obtained from cells transfected with empty vectors and 
cultured at 25mM K were set as one-fold induction. 
4.3.4.f IL-1beta immunodetection by ELISA 
IL-1β release was measured by enzyme-linked immunosorbent assay (ELISA). A 
mouse IL-1β ELISA kit (Pierce/Thermo scientific) was used to quantify the presence 
of IL-1β in the supernatant of DIV6 neuronal/glial cerebellar cultures from P4 
C57Bl/6 mice, treated with 100 ng/mL LPS for 24 h. Conditioned media were then 
collected, and the assay was completed following the manufacturer’s instructions. 
Sample absorbance was measured with a spectrophotometric system (1420 
Multilabel Counter Victor 2; Wallac) at 450 nm. The actual IL-1β concentration was 
estimated on the basis of a standard curve at known concentration of recombinant 
mouse IL-1β (provided by the Kit). 
1. Sample preparation  
100μl per well of Bergmann glia culture supernatant is required. Store the samples 
to be assayed within 24 hours at 2-8°C. For long-term storage, aliquot and freeze 
samples at -70°C. Avoid repeated freeze-thaw cycles when storing samples. Test 
samples and standards must be assayed in duplicate each time the ELISA is 
performed. Gradually equilibrate samples to room temperature before beginning 
assay. Reconstitute the standard with ultrapure water. Mix by gently inverting vial. 
The reconstituted standard will be at 4000pg/mL. Label eight tubes, one for each 
standard curve point: 2000, 1000, 500, 250, 125, 62.5, 31.25 and 0pg/mL. Prepare 
1:2 serial dilutions for the standard curve as follows: Pipette 250μL of Standard 
diluent into each tube. Pipette 250μL of the reconstituted standard into the first tube 
(i.e, 2000pg/mL) and mix. Pipette 250μL of this dilution into the second tube 
(1000pg/mL) and mix. Repeat the serial dilutions (using 250μL) five more times to 
complete the standard curve points. 
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2. Assay procedure 
Sample Incubation 
Add 100μl of Standards or test sample in duplicates to each well. Mix the well by 
gently tapping the plate several times. Cover the plate with new adhesive cover. 
Ensure all edges and strips are sealed tightly. Incubate 2hrs at room temperature. 
Remove cover and wash the plate three times with wash buffer by using squirt bottle 
to fill wash buffer vigorously to each well. 
3. Biotinylated antibody reagent Incubation 
Add 100μL of Biotinylated Antibody Reagent to each well containing sample or 
standard and attach new adhesive cover, ensure all edges and strips are tightly 
sealed. Incubate the plate for one hour at room temperature, 20-25°C. Carefully 
remove the adhesive plate cover, discard plate contents and wash three times with 
wash buffer 
4. Streptavidin-HRP solution preparation and Incubation 
Prepare Streptavidin-HRP Solution immediately before use. For each strip, mix 
2.5μL of Streptavidin-HRP Concentrate with 1mL of Streptavidin-HRP Dilution 
Buffer. Store Streptavidin-HRP Concentrate reserved for additional strips at 2-
8°C.Add 100μL of prepared Streptavidin-HRP Solution to each well. Carefully attach 
a new adhesive plate cover, ensuring all edges and strips are tightly sealed. 
Incubate plate for 30 minutes at room temperature, 20-25°C. Carefully remove the 
adhesive plate cover, discard plate contents and wash three times with wash buffer. 
5. Substrate Incubation and stop step 
Pipette 100μL of TMB Substrate into each well. Allow colour reaction to develop at 
room temperature in the dark for 30 minutes. Do not cover plate with aluminium foil 
or a plate sealer. The substrate reaction yields a blue solution that turns yellow when 
Stop Solution is added. After 30 minutes, stop the reaction by adding 50μL of Stop 
Solution to each well. 
6. Absorbance measurement 
Note: Evaluate the plate within 15 minutes of stopping the reaction. Measure the 
absorbance on an ELISA plate reader set at 450nm and 550nm. Subtract 550nm 
values from 450nm values to correct for optical imperfections in the microplate. If an 
absorbance at 550nm is not available, measure the absorbance at 450nm only. 
When the 550nm measurement is omitted, absorbance values will be higher. 
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4.3.4.g Mass spectrometry and protein Identification 
1. Materials 
Solvents (CH3OH, CH3CN, and H2O, HPLC grade), reagent (CH3COONa, KCl, 
EDTA, pure g99.5%), trifluoroacetic acid (HPLC grade, pure g99.0%), pepsin, and 
3,5-dimethoxy-4-hydroxycinnamic acid (pure g99.0%), R-cyano-4-hydroxy-trans-
cynnamic acid (R-CHCA, pure g99.0%) were purchased from Sigma Aldrich Fluka 
(Milano, Italy). HAP (BIO-GEL HTP) was purchased from Biorad (Milan, Italy). 
2. In-gel digestion 
For MS analysis, the spots of interest were excised from 1-DE gels and analyzed by 
matrix-assisted laser desorption ionization/time-of-flight (MALDI-TOF/TOF). After 
SDS PAGE, discrete band was excised from the blue-coomassie-stained gel. The in-
gel digestion with proteinase K was carried out as previously described (Napoli et 
al., 2010). To obtain extensively cleaved protein the digestion was performed at 37 
°C for 18 hrs twice. Peptides were subsequently extracted twice with 100 μL of 50% 
ACN/2% trifluoroacetic acid (TFA); the extracted solutions were then combined and 
dried with the Speed Vac concentrator. The peptide pellets were then resuspended 
in 100 μL of 40% ACN/0.1%. For MS MS/MS experiments, the peptic peptide 
mixture (10μL) was desalted and concentrated in ZipTipC18 devices (Millipore). 
3. Optimized enrichment procedure for phosphopeptides 
Hydroxyapatite affinity chromatography (HAP) was performed in order to obtain an 
enriched fraction of phosphopeptides. HAP spin down column was manufactured in 
our laboratory using BIO-GEL HTTP/ sample ratio 2:1(mg/μL). 10mL of the 
reconstituted peptides mixture was dried in a vacuum centrifuge and resuspended in 
100μl of loading buffer (TRIS 10mM, EDTA, 1mM pH 7). The peptides solution was 
loaded onto 20mg of HAP that was previously packed with loading buffer. The HAP-
bound peptides were incubated at room temperature for 15 min twice. After, the 
column was washed with loading buffer to remove un-retained peptides. The 
phosphopeptides were eluted with 100 μl of elution buffer (KCl 100 mM, TRIS 
20mM, EDTA 2 mM, pH 8). All fraction, were dried in a vacuum centrifuge, 
resuspended in 100 μL of 40% ACN/0.1%, desalted in reverse-phase Zip Tips. 
4. Protein Identification by MALDI MS and MS/MS analysis 
10 μl of the all fractions was desalted using ZipTipC18 prior MS analysis. Peptides 
was elute directly into 5 μl of matrix solution (5 mg/μL R-cyano-4-hydroxycinnamic 
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acid (CHCA) in 50% ACN, 0.1% v/v TFA) in order to maximize concentration of 
peptides in sample spot. Mass spectrometry analyses were performed using a  5800 
MALDI TOF-TOF Analyzer (AB SCIEX) equipped with a neodymium: yttrium-
aluminum-garnet laser (laser wavelength was 349 nm), in reflection positive-ion 
mode with a mass accuracy of 5 ppm. At least 4000 laser shots were typically 
accumulated with a laser pulse rate of 400 Hz in the MS mode, whereas in the 
MS/MS mode spectra up to 5000 laser shots were acquired and averaged with a 
pulse rate of 1000 Hz. MS/MS experiments were performed at a collision energy of 
1kV, ambient air was used as collision gas with medium pressure of 10-6 Torr. After 
acquisition, spectra were handled using Data Explorer version 4.0. For peptide mass 
fingerprinting, MASCOT (http://www.matrixscience.com) search engines were used. 
c-Jun was identified based on the assumptions that peptides were monoisotopic. 
The search was performed using the human protein database of the swiss prot. A 
mass tolerance of 50 ppm was used and up to 4 missed pepsin cleavage was 
allowed. 
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5 Objective of the work 
In the central nervous system, activation of the c-Jun transcription factor by the c-
Jun-N-terminal kinase (JNK) plays an important role in various cellular programs, 
including neuronal differentiation, repair and apoptosis. JNK induces c-Jun activity 
by phosphorylating its N-terminal domain at both serine (S) 63/73 and threonine (T) 
91/93 residues. However, these two groups of phosphorylation are differentially 
regulated, as the S63/73 sites are promptly phosphorylated upon JNK activation, but 
can also be phosphorylated by other proline-directed kinases, while phosphorylation 
at T91/93 is strictly dependent on JNK activity and requires a priming 
phosphorylation event at the adjacent T95Q96 site. A wide number of studies have 
shown that c-Jun phosphorylation at the S63/73 sites acts in both degenerative and 
regenerative pathways of the CNS, suggesting that additional phosphorylation at the 
T91/93 sites may be crucial for c-Jun degenerative activity. 
Our aim was to investigate the role and regulation of c-Jun phosphorylation at 
T91/93/95 in neuronal cell death. As paradigm of neuronal cell death, we have 
chosen the potassium/trophic deprivation of cerebellar granule cell (GCs), which 
triggers  apoptosis in a way that is dependent on JNK-dependent activation of c-Jun. 
On the other side, it is known that lithium counteracts GC apoptosis by inhibiting 
GSK3 activity, without interfering with JNK activation. Therefore, how GSK3 activity 
is  linked to c-Jun-dependent apoptosis of GCs remain to be elucidated. We have 
investigated the regulation and function of site-specific regulation of c-Jun 
phosphorylation at the S63 and T91/T93 JNK sites in cerebellar granule cells CGC 
apoptosis by trophic/potassium (TK) deprivation. We found that lithium protects 
CGCs from TK deprivation by inhibiting multisite phosphorylation of c-Jun at 
T91/T93/T95, which triggers the onset of c-Jun pro-apoptotic activity. Furthermore, 
we show that abrogation of T91/T93/T95 phosphorylation has no consequence on 
the capacity of c-Jun to induce neurite outgrowth in PC12 cells, suggesting that site-
specific regulation of c-Jun phosphorylation is one possible mechanism underlying 
the functional dichotomy of the JNK/c-Jun pathway in the brain. 
 
On the other hand, the JNK/c-Jun pathway is involved in the up-regulation of 
inflammatory cytokines in activated immune-regulatory cells of the cerebrum and 
spinal astrocytes (Waetzig et al., 2005; Raivich, 2008; Haeusgen et al., 2009). In 
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contrast, little is known about the expression and activation of c-Jun in Bergmann 
glial (BG) cells. We have used neuronal/glial cultures of mouse neonatal cerebellar 
cells to assess putative roles of c-Jun in activated Bergmann glial cells. We provide 
evidence that the induction of IL-1β gene expression in response to LPS, the major 
structural component of the outer wall of gram-negative bacteria and a potent 
activator of astrocytes and microglia, is dependent on c-Jun. Furthermore, c-Jun 
expression in BG cells was confirmed in vivo by characterizing the cell-type and 
layer-distribution of c-Jun-expressing cells in the early postnatal cerebellum. In the 
present study, we have used neuronal/glial cultures of mouse neonatal cerebellar 
cells to assess putative roles of c-Jun in activated Bergmann glial cells. We provide 
evidence that the induction of IL-1β gene expression in response to LPS, the major 
structural component of the outer wall of gram-negative bacteria and a potent 
activator of astrocytes and microglia, is dependent on c-Jun. Furthermore, c-Jun 
expression in BG cells was confirmed in vivo by characterizing the cell-type and 
layer-distribution of c-Jun-expressing cells in the early postnatal cerebellum. 
Results 
66 
6 Results 
6.1 Role of c-Jun in neuronal cell death 
6.1.1 Phosphorylation of c-Jun N-terminal domain in cerebellar 
granule neurons 
To investigate the possible regulative role of c-Jun phosphorylation at 
T91/T93 in neuronal death, we set up a previously described experimental system 
consisting in primary cultures of mouse CGCs undergoing c-Jun-dependent 
programmed cell death in response to trophic/potassium (TK) deprivation (Watson 
et al., 1998). P7 mouse cerebella were used to generate CGCs, which were cultured 
for 7 days (DV7) in presence of serum and high potassium concentration (25mM); 
CGC culture were then switched to low potassium concentration (5mM) for further 
18 hours. Cell death of CGCs was assessed at single cell level by examining 
nuclear morphology of DAPI-stained nuclei using immunofluorescence microscopy. 
It is worth noting that in our experimental settings (Fig 6.1 AI - A III) 100% of DAPI-
stained condensed nuclei resulted TUNEL-positive, confirming that morphological 
analysis of DAPI-stained nuclei is a valuable assay to detect cell death. In line with 
previous studies (Hongisto et al., 2003; Ambacher et al., 2012) fig 6.1 IV shows that 
approximately 55% of cells presented condensed nuclei in TK-deprived CGC 
cultures, whereas the JNK-specific inhibitor SP100125 (SP) and lithium reduced the 
frequency of condensed nuclei to 8% and 18%, respectively. 
 
Once established that cell death was dependent on JNK activity and sensitive to 
lithium, we then investigated the regulation of site-specific c-Jun N-terminal 
phosphorylation by TK deprivation, using site-specific c-Jun antibodies recognizing 
c-Jun when phosphorylated at S63 (c-Jun-p63) or at T91/T93 (c-Jun-p91/93), or for 
total-c-Jun. Site-specific c-Jun phosphorylation was analysed by western-blot 
analysis at 4 hrs after TK deprivation, as maximal c-Jun N-terminal phosphorylation 
by TK was reported to arise at this time period (Coffey et al., 2002). As shown in 
fig.1B, we found that TK deprivation induced c-Jun protein levels and c-Jun 
phosphorylation at both S63 and T91/T93 in a SP-sensitive manner (Fig 6.1B-C). 
This finding is in agreement with several previous studies demonstrating that both c-
Jun expression and N-terminal phosphorylation are dependent on JNK activity 
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(Morton et al., 2003; Hess et al., 2004; Karin & Gallagher, 2005). In contrast, lithium 
significantly impaired T91/T93 phosphorylation, whereas had no effects on S63 
phosphorylation or JNK activation. These results are in line with recent studies by 
Ambacher and co-workers, reporting that inhibition of the lithium-sensitive kinase 
GSK3 β in CGCs protects from TK deprivation-induced apoptosis, but has no effect 
on either JNK activation or c-Jun phosphorylation on S63 (Ambacher et al., 2012). 
Similarly, an earlier study by Hongisto and co-workers has shown that the protective 
effect of lithium on CGCs is coupled to inhibition of c-Jun target genes, without 
affecting JNK activation (Hongisto et al., 2003). However, neither study investigated 
the levels of T91/T93 phosphorylation, therefore missing the site-specific effect of 
either lithium or GSK3 β inhibitors on c-Jun phosphorylation. 
 
Next, we confirmed the pattern of S63 and T91/93 phosphorylation at single cell 
level. To this aim, we used site-specific c-Jun phospho-antibodies or total-c-Jun 
antibodies to perform immunofluorescence analysis of c-Jun phosphorylation after 4 
hrs of TK-deprivation (Fig 6.1D-F). In addition, parallel CGC cultures were TK-
deprived for 18 hrs and analysed for condensed nuclei by DAPI staining (Fig 6.1G). 
As shown in fig 6.1D-H, the percentage of TK-deprived cells resulting positive for 
either total-c-Jun or c-Jun-p63 antibodies were very comparable, indicating that c-
Jun was phosphorylated at S63 in the vast majority of c-Jun-expressing cells (70% 
of total cells). On the other hand, the percentage of cells positive for c-Jun-p91/93 
was circa 55% of total TK-deprived cells, indicating that extensive N-terminal 
phosphorylation at both S63 and T91/T93 is present only in a subpopulation of c-
Jun-expressing cells. This finding suggests that TK-deprivation differentially 
regulates S63 and T91/T93 phosphorylation of c-Jun, with the T91/T93 sites 
responding in a sensitive fashion and mirroring the switch-like apoptotic response of 
TK-treated CGCs (compare the percentage of apoptotic cells with that of T91/T93 
positive cells). 
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Fig 6.1: c-Jun N-terminal phosphorylation in cerebellar granule neurons. A 
TUNEL assay of CGCs. Confocal analysis of CGCs cultured in 25mM K and then 
switched to 5mM K medium for 18 hrs. Cells were then fixed and nuclei were either 
stained with DAPI (Gaudilli+¿re et al.) or by TUNEL (A II) or Merge (A III) staining as 
described in methods. A IV Cerebellar granule cells (CGCs) were cultured in 25mM 
K and then switched to 5mM K medium for 18 hrs, either in absence or in presence 
were stained with DAPI. Condensed nuclei were counted by fluorescence 
microscopy. Columns indicate the average percentage number of condensed nuclei 
present in 10 different fields, with bars indicating SD. B Western blot analysis of 
CGCs cultured either in 25mM K or 5mM K medium for 4 hrs and treated with either 
SP600125 (10mM) or LiCl (10mM) as indicated. c-Jun N-terminal phosphorylation or 
phosphorylated JNK (p-JNK), were determined by using the indicated antibodies. c-
Jun expression levels were measured by using a total c-Jun antibody, as indicated. 
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Protein levels were normalized by using the Mcm7 antibody. C Densitometric 
analysis of western blot analysis shown in panel C. Values are presented as optical 
density (OD; expressed in arbitrary units) relative to the control (Mcm7). Bars 
represent SD from three different densitometric quantification of analogous 
experiments shown in panel C. D-F Immunofluorescence analysis of CGCs cultured 
in 25mM K or 5mM K medium for 4 hrs and treated with either SP600125 (10mM) or 
LiCl (10mM) as indicated. Cells were then fixed and nuclei were stained with DAPI; 
c-Jun N-terminal phosphorylation and expression was detected by 
immunocytochemical staining using c-Jun-p63 Ab (D), or c-Jun-pT91/T93 (E), or c-
Jun total Ab (F). G Immunofluorescence analysis of CGC cultures TK-deprived for 
18 hrs and analysed for condensed nuclei by DAPI staining. H Quantification of 
results shown in D-G. Columns indicate the average percentage number of 
immunoreactive cells (D-F) or condensed nuclei (G) present in 10 different fields, 
with bars indicating SD. 
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6.1.2 Lack of T91/93 phosphorylation impairs cell death but not 
neurite outgrowth 
  As c-Jun phosphorylation at T91-93 is dependent on the T95 priming site 
(Vinciguerra M et al 2008), we then validated the role of the T91/T93 sites in 
neuronal cell death by analysing a c-Jun mutant bearing alanine substitution of T95 
(c-JunA95). This c-Jun mutant has been previously described to lack T91/T93 
phosphorylation in response to anisomycin, UV radiation and etoposide (Vinciguerra 
et al., 2008). 
 
To this aim, we used a lentiviral approach to reintroduce the expression of either 
influenza-hemagglutinin (HA)-tagged c-Jun-wt or c-JunA95 proteins in primary 
CGCs cultures generated from conditional KO mice lacking c-Jun expression in the 
CNS Fig (6.2A-6.2C) (c-Jun DN mice) (Vinciguerra et al., 2004). Since the 
percentage of lentiviral-infected cells was circa 70% of total cells, we used the non-
infected cells as internal control. As expected from previous studies, Fig 6.3C shows 
that the rate of TK-induced apoptosis resulted reduced in CGCs generated from 
JunDN mice (19% versus 60% of c-Jun-expressing CGCs). In contrast, TK- 
deprivation efficiently induced cell death in CGCs expressing c-Jun-wt proteins. In 
contrast, cell death was impaired in CGCs expressing the c-JunA95 mutant. These 
results indicate that reintroduction of c-Jun-wt expression, but not that of the c-
JunA95 mutant, restores the standard rate of CGC apoptosis by TK-deprivation in c-
JunDN mice. Notably, c-Jun-wt was fully phosphorylated at both S63 and T91/T93 in 
response to TK deprivation, whereas N-terminal phosphorylation of c-JunA95 was 
restricted to S63 (Fig 6.3D), confirming the crucial role of the T95 site in priming 
T91/T93 phosphorylation by TK-deprivation. 
 
As c-Jun functions as a transcriptional factor, we next evaluated whether the inability 
of the c-JunA95-HA mutant to rescue TK-induced apoptosis was coupled to the lack 
of c-Jun activity. To this end, we carried out reporter gene assays using a Jun2-
luciferase (Jun2-luc) reporter, previously shown to be induced by TK-deprivation in 
murine CGCs and containing 2 copies of the c-Jun/AP-1 target site “TTACCTCA” 
(Yuan et al., 2009). The Jun2-luc reporter was transfected by calcium phosphate 
method in CGCs generated from c-JunDN mice, either alone or together with 
expression vectors expressing either c-Jun-wt-HA or c-JunA95-HA proteins. As 
5mM+ LiCl 
Results 
73 
shown in figure 6.3E, the c-Jun-luc reporter was not induced by TK-deprivation, in 
agreement with the lack of endogenous c-Jun expression in CGCs from c-JunDN 
mice. Conversely, re-introduction of c-Jun-wt-HA caused approximately a 3-fold 
increase of luciferase activity in response to TK-deprivation, whereas c-JunA95-HA 
had a very limited effect. Notably, the western analysis shown in figure 6.3D 
indicates that c-Jun-wt-HA and c-JunA95-HA proteins have equal steady-state 
expression levels in CGCs. Taken together, these results suggest that lack of c-Jun 
phosphorylation at the T91/T93/T95 sites impairs the induction of c-Jun activity by 
TK-deprivation and in turn protects from cell death. 
 
Next, we investigated the capability of the c-JunA95 mutant to induce neurite 
outgrowth in PC12 cells cultured in absence of NGF, a well described process that 
is induced by ectopic expression of c-Jun and depend on S63/S73 phosphorylation 
(Leppa et al., 1998; Dragunow et al., 2000). As shown in figure 6.4, c-Jun-wt and c-
JunA95 were equally able to induce neurite outgrowth in naïve PC12 cells. These 
results exclude that the effect of the c-JunA95 mutant on cell death was secondary 
to a defect altering c-Jun activity independently of T91/T93 phosphorylation. Also, 
they establish that c-Jun phosphorylation on T91/T93/T95 is required for neuronal 
cell death of CGCs, whereas it has no roles in Jun-dependent neurite outgrowth in 
naïve PC12 cells. 
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A 
SV40 promoter/ori 8331...8676
F1 ori 7881...8187
BGH polyA 7577...7734
tar 7383...7439
SIN LTR 7062...7565
XhoI disruption 6866...6873
WPRE 6258...6849
FUV rev sequencing primer 6305...6326
eGFP_IRES2vector 5517...6236
eGFP_C1 5517...6124
ble/r 8749...9123
SV40 polyA 9254...9385
M13-rev 9439...9419
LacO 9467...9445
562_FUVal_c-
JunHA_IRES2_
GFP
11577 bp
CMV 213...800
5'LTR delta tar 808...1014
PBS 1017...1034
PacI disruption 2600...2614
ColE1 origin 10489...9807
Amp/r 10590...11436
AmpR 11246...10587
NCR 1015...1170
psi 1132...1177
gag/p17 1171...1261
HIV ORF unknown 1566...2453
cPPT 2448...2576
Ubiquitin C 2615...3781
IRES2 4929...5513
4920 NotI (1)
HA 4860...4919
c-Jun 3871...4859
Kozak 3864...3870
3859 BamHI (1)
FUV for sequencing primer 3808...3827
 
 
B 
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Fig 6.2: Generation of lentivirus constructs: A) Vector back bone used for lenti 
viral constructs- influenza-hemagglutinin (HA)-tagged c-Jun-wt or c-JunA95 proteins. 
B) Schematic representation of lentiviral expression of c-Jun in primary CGCs of 
CNS specific c-Jun conditional knockout mice. C) The efficiency of lenti viral 
transduction in HELA and CGCs. 
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Figure 6.3: Lack of T91/93 phosphorylation protects from cell death. A-B 
Confocal analysis of CGCs generated from c-Jun-DN mice and infected with GFP-
tagged lentivius particles expressing either hemagglutinin (HA)-tagged c-Jun 
proteins: c-Jun-wt-HA (A) or c-JunA95-HA (B). After infections, cells were cultured 
for 6 days and then treated as indicated for 18 hrs. After fixation, nuclei were stained 
by DAPI and immunostained with HA antibody. C Quantification of results shown in 
A-B. Columns indicate the average percentage number of condensed nuclei present 
in 10 different fields, with bars indicating SD. D Western blot analysis of CGCs from 
c-Jun-DN mice infected with lentiviurs as described in A-B. After infection, cells were 
cultured either in 25mM K or shifted to 5mM K medium for 4 hr, as indicated. Control 
represents not infected CGCs. c-Jun N-terminal phosphorylation was determined by 
using the indicated c-Jun phospho-specific antibodies. The levels of c-Jun-HA 
proteins was determined by using the HA antibody. Protein levels were normalized 
by using the NFL antibody. E CGCs from c-Jun-DN mice were transfected with 
Jun2-luc reporter plasmids in combination with plasmids expressing either c-Jun-wt-
HA or c-JunA95-HA proteins or empty vector (indicated as control). After infection, 
cells were cultured either in 25mM K or shifted to 5mM K medium for 4 hr, as 
indicated. The luciferase activities were normalized to the internal transfection 
control. Values of CGCs transfected with empty vectors and cultured in 25mM K 
were set as 1-fold induction. Bar graphs represent the mean ±SD of three 
independent assays. 
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Figure 6.4: Lack of T91/93 phosphorylation does not impair neurite outgrowth. 
A Confocal analysis of PC12 cells were cultured either in absence or in presence of 
NFG (72 hrs) as indicated. After fixation, cells were immunostained with 
Neurofilament (NLF, green) antibodies. Nuclei were stained with DAPI B Naive 
PC12 cells were transfected with DNA constructs expressing either HA-tagged c-
Jun-wt or Ha-tagged c-JunA95 constructs, as indicated. Transfected cells were 
cultured in absence of NGF for 72 hrs; after fixation cells were incubated with either 
HA (red) or Neurofilament (NLF, green) antibodies. C Quantification of PC12 cells 
presenting neurites. 
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6.1.3 Deregulation of c-Jun phosphorylation at the T91/T93 sites 
recovers cell death in presence of lithium 
The phosphorylation pattern of site-specific c-Jun phosphorylation presented 
in fig.1, together with the evidence that the c-JunA95 mutant protects from cell 
death, suggests that lithium may inhibit the priming event preceding T91/T93 
phosphorylation. To assess this hypothesis, we used a c-Jun mutant bearing 
aspartate substitution of T95 (c-JunD95), which was previously shown to acquire the 
same kinetic of S63/S73 phosphorylation in response to JNK activation (Vinciguerra 
et al., 2008). As shown in figure 4, we found that whereas lithium strongly impaired 
TK deprivation-induced apoptosis in CGCs expressing c-Jun-wt proteins (Fig 6.5A), 
it had a poor protective effect in GCGs expressing c-JunD95 mutated proteins (Fig 
6.5B). However, the JNK inhibitor SP100125 efficiently inhibited LK-induced 
apoptosis in both circumstances, excluding that the c-JunD95 mutant acts 
independently from JNK activation (Fig 6.5A-C). These results suggest that inhibition 
of T91/93/95 phosphorylation underlies the effect of lithium on cell death. 
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Figure 6.5: Constitutive phosphorylation at T95 impairs the neuronal 
protection ability of Li 
Confocal analysis of CGCs generated from c-Jun Dn mice and infected with 
lentivirus particles expressing Ha-c-Jun-wt (A) or Ha-c-Jun D95 (B). After 
transduction cells were cultured for 6 days and then treated as indicated with 25mM 
K or 5mM k with or without JNK and GSK3 inhibitors for 20hrs. After fixation, nuclei 
were stained by DAPI and immunostained with HA antibody (red). C Quantification 
of results shown in A-B Columns indicates the average percentage number of 
condensed nuclei present in 10 different fields, with bars indicating SD. 
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6.1.4 The T95 site of c-Jun is phosphorylated in vivo 
Our results suggest that lithium controls c-Jun pro-apoptotic activity by 
regulating the priming event preceding T91/93 phosphorylation. Most probably, the 
priming event consists in phosphorylation of the T95 sites, as suggested by the 
finding that the c-JunD95 overcomes the effect of lithium on cell death. To exclude 
that a different post-translational modification of T95 primes T91/93 phosphorylation, 
we validated that T95 is phosphorylated in cells. To this aim, we firstly attempt to 
generate phospho-T95-specific antibodies. Unfortunately, the produced antibodies 
were not able to distinguish between phospho-T95 and phospho-T91/T93 residues 
of c-Jun proteins (data not shown). Hence, we used mass spectrometry 
methodologies to identify N-terminal phosphopeptides of c-Jun proteins ectopically 
expressed in HEK-T 293 cells. Mass spectrometric methodologies provide a rapid 
and sensitive tool for the identification and quantification of proteins and their post-
translational modifications including phosphorylation (Hernandez et al., 2006; Napoli 
et al., 2008). Firstly, we performed analytical experiments to analyze the N-terminal 
phosphorylation of ectopically expressed c-Jun proteins in HEK-T 293 cells. To this 
aim, HEK-T 293 cells were transfected with a vector expressing human c-Jun and 
than treated with anisomycin, a strong activator of JNKs. As shown by western blot 
analysis, c-Jun resulted fully phosphorylated on both S63 and T91/T93, either 
before or after anisomycin treatments (Fig 6.6A). The high basal levels of c-Jun 
phosphorylation in HEK-293T cells has been previously described and it is due to 
the constitutive activation of JNKs in this cell line (Nateri et al., 2005). However, c-
Jun phosphorylation at T91/T93 was dependent on the priming event at T95, as the 
c-JunA95 mutant resulted phosphorylated only at the S63 site (6.6B). Next, c-Jun-wt 
proteins were immunoprecipitated from transfected cells using a pan-c-Jun antibody, 
immunocomplexes were then purified on PAGE, comassie stained and processed 
for MALDI-MS and MS/MS. In parallel, analytical aliquots of immunocomplexes were 
analyzed by western analysis to confirm the presence of phosphorylated T91/T93 
residues in c-Jun-immunocomplexes (fig.6.6B). 
 
Following in gel digestion of c-Jun immunocomplexes with proteinase K (PK), the 
fraction of phosphopeptides was enriched by hydroxyapatite affinity chromatography 
(HAP) and analyzed by MALDI MS and MS/MS. The mass data were processed to 
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assign candidate peptides in the SwissProt database using the MASCOT search 
program. Peptide Mass Fingerprinting (PMF) interrogation identified (P05412), 
TRANSCRIPTION FACTOR AP-1 (PROTO-ONCOGENE c-JUN) (P39) (G0S7) 
using 34 m/z values, sequence coverage: 62%, (score 91). All identified 
phosphopeptides are listed in Table 6.1. In-gel PK digestion of c-Jun 
immunocomplexes generated three major phosphorylated peptides. In particular, 
three different three-phosphopeptides were identified as residues 80-97, 82-97 and 
89-98. The CID spectrum of segment 82-97 (m/z 1956.73) is given in figure 6.6C. 
For this segment, the MS/MS spectrum showed b (b-H3PO4) and y (y-H3PO4) ion 
series, allowing the assignment of either peptide sequence and phosphorylation 
sites at the T91, T93 and T95 residues. All the b-series fragments down to b10 
(m/z1107.7) showed the ability to lose H3PO4 (-98 Da), while the b9 (m/z 926.7) 
fragment was present only in a non-phosphorylated state, indicating that the ninth 
residue from the N-terminus (T91) is phosphorylated. In addition, the mass 
difference between the b10 (m/z 1107.7) and b9 (m/z 926.7) ions is consistent with 
the mass of a phospho-threonine residue (181Da). Furthermore, the presence of the 
ion peak b14-98 (m/z 1566.0) and of the unmodified counterpart y2 (m/z 294.2) is 
consistent with a phosphorylated T95 residue. The presence of T95 phosphorylation 
is also reliable with the mass difference between the y2 (m/z 294.2) and y3 (m/z 
475.1) ions (181Da). Accordingly, T93 phosphorylation was assigned by considering 
the mass difference between the y5-98 (m/z 655.4) and y4-98 (m/z 474.4) ions, as it 
was consistent with the mass of a phosphothreonine residue (181Da). In a similar 
fashion, both phosphopeptides 80-97, 89-98 resulted to be phosphorylated on T91, 
T93 and T95. A similar set of b (b-H3PO4) and y  (y-H3PO4) ions was observed for 
both the doubly phosphorylated peptide (83-93) of m/z 1473.58, and the mono-
phosphorylated peptide (82-97) of m/z 1796.80, allowing the assignment of T91-T93 
and T91 phosphorylations, respectively (Fig. 6.7A-B,). Figure 5B shows the MS/MS 
spectrum for the precursor ion of m/z 1144.57 of sequence TpSDVGLLK. 
Interpretation of the MS/MS spectrum was straightforward because a complete b (b-
H3PO4) and y ion series was identified, with the b2-98 fragment indicating that 
phosphorylation occurred at the second residue from the N-terminus. This 
phosphorylation site was unambiguously assigned to S63. Similarly, 
phosphopeptides 56-69 and 61-68 resulted to be phosphorylated at S63. 
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Table 6.1: a Amino acid sequence of phosphorylated peptides identified from peptic 
digests on the basis of their CID spectrum. pS denotes phosphoserine, and pT 
denotes phosphothreonine, * denotes [M-Na]+adduct. bAll mass values are listed as 
monoisotopic mass. 
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Figure 6.6: Phosphorylation of amino acid residues within c-Jun N-terminal 
domain. A Western blot analysis of HEK-293 cells transfected with DNA constructs 
expressing either HAtagged c-Jun-wt or Ha-tagged c-JunA95, as indicated. After 
transfection, cells were treated either without or with Anisomycin (100 ng/ml) for 
indicated time-periods. c-Jun N-terminal phosphorylation was determined by using 
the indicated antibodies. B Lysates from anisomycin treated c-Jun-wt-transfected 
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HEK-T cells were immunoprecipitated using the c-total c-Jun antibody, then aliquots 
from c-Jun-immunocomplexes were analysed by western blot using either c-Jun total 
antibodies (left panel) or c-Jun-p91/93 antibodies (right panel). C MALDI MS/MS 
spectra of the [M+H]+ of segment 82-97 carrying three phosphate groups at T91, 
T93 and T95. D MALDI MS/MS spectra of the [M+Na]+ of segment 62-70 carrying 
one phosphate group at S63. The a, b, and y ions are labelled in each spectrum, as 
well as b or y ions corresponding to the neutral loss of phosphoric acid (-98). 
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Fig 6.7: A) MALDI MS/MS spectra of the  [M+H]+ from segment 83-95. a, b, and y 
ions are labelled in the spectrum, as well as b or y ions corresponding to the neutral 
loss of phosphoric acid (-98). 
B) MALDI MS/MS spectra of the [M+H]+ from segment 82-97. a, b and y ions are 
labelled in the spectrum, as well as b or y ions corresponding to the neutral loss of 
phosphoric acid (-98). 
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6.1.5 JNK-1 phosphorylates T91/93 residues of recombinant c-Jun 
proteins in vitro 
Our present results together with previous studies show that JNK activity is 
strictly required for c-Jun phosphorylation at T91/93 in response to various stimuli 
and in different cell types (Morton et al., 2003; Madeo et al., 2010). Yet, whether the 
T91/93 sites can be directly phosphorylated by JNK or by a putative JNK-induced 
kinase remains to be assessed. To resolve this question and to assess whether T95 
phosphorylation is directly achieved by JNK or by a lithium-sensitive kinase, we set 
up in vitro phosphorylation assays for recombinant c-Jun proteins. To this aim, we 
generated recombinant GST-fused proteins containing the N-terminal portion of 
either c-Jun-wt, or c-JunA63/73 or c-JunA95 proteins (Fig 6.8). Purified GST/c-Jun 
proteins were then used in vitro phosphorylation assays using recombinant JNK-1 
kinase. Site- specific phosphorylation of c-Jun was analyzed by western blot using 
phospho-specific antibodies for p-S63 or p-T91/93. As shown in figure 6A, JNK-1 
was fully capable to phosphorylate S63 both in GST/c-Jun-wt and GST/c-Jun-A95 
proteins, but not in GST/c-Jun-A63 proteins, indicating that in vitro phosphorylation 
of GST/c-Jun proteins by JNK-1 is highly specific for JNK sites. Notably, JNK-1 fully 
phosphorylated the T91/93 sites in both GST/-Jun-wt and GST/c-JunA63 proteins 
but not in GST/c-JunA95 proteins, confirming in vitro the dependence of T91/93 
phosphorylation on the priming T95 site. In contrast, recombinant GSK3 β, used 
alone or in combination with JNK-1, had no effect on either sites of c-Jun 
phosphorylation (fig.6.9). These results suggest that JNK-1 is fully able to directly 
phosphorylate c-Jun at the canonical JNK T91/93 and at the T95 priming site. 
However, we cannot exclude that in vivo a lithium-sensitive kinase different from 
GSK3 β is the main kinase phosphorylating the priming T95 site. 
 
Having shown that T95 is phosphorylated in vivo, we also asked whether the T95 
site could be directly phosphorylated in vitro by JNK or by the lithium-sensitive 
kinase GSK3 β on immunoprecipitated c-Jun protein. To this end, we transfected 
NSC-34 cells with plasmids expressing either c-Jun-wt-HA or c-JunA95-HA tagged 
proteins and performed in vitro phosphorylation of immunoprecipitated c-Jun-HA  
proteins by using HA antibodies. c-Jun-HA immunocomplexes were then used as 
substrates for in vitro phosphorylation assays by using recombinant JNK-1, either 
alone or in combination with recombinant GSK3β. Given that T91/T93 
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phosphorylation is strictly dependent on the priming phosphorylation event at the 
T95 site, we assumed that the phosphorylation status of T91/T93 could indirectly 
monitor the capacity of either JNK or GSK3β to phosphorylate T95. Therefore, 
products of in vitro phosphorylation reactions were analyzed by western blot using 
phospho-specific antibodies for either p-T91/T93 or for p-S63. Since western 
analysis of NSC-34 total extracts revealed that Jun-HA proteins have quite low basal 
phosphorylation levels of the T239 GSK3β site, but fairly good levels of the T243 
priming site for T239 phosphorylation (Fig 6.10A), we also monitored the 
phosphorylation status of the T239 by using a p-T239 phospho-specific antibody. As 
shown in the new fig 6.10B, recombinant JNK-1 was fully able to phosphorylate 
immunoprecipitated c-Jun-wt-HA at both S63 and T91/93 sites, whereas JNK-1 
phosphorylated immunoprecipitated c-JunA95-Ha proteins only at the S63 site. In 
contrast, recombinant GSK3bβ had no effect of either S63 or T91/93, but t it was 
fully able to phosphorylate both forms of c-Jun-HA proteins at the T239 site. It’s 
worth to note that the mobility shift of c-Jun-HA proteins detected by HA-Ab (in the 
samples incubated with JNK-1) is due to S63 phosphorylation and therefore is 
observed in both c-Jun-wt-Ha and c-Jun-A95-HA proteins. 
 
To rule out that that T95 phosphorylation of c-Jun-HA immunocomplexes was 
achieved by a c-Jun-interacting kinase different from JNK, we then performed in 
vitro phosphorylation of FL c-Jun recombinant protein. As shown in the new fig 
6.10C, we found that recombinant JNK-1 was able to phosphorylate recombinant 
FL-c-Jun at both the S63 and T91/93 sites. All together these experiments indicate 
that JNK-1 is fully able to directly phosphorylate c-Jun at the canonical JNK T91/T93 
sites and at the non-canonical T95 site. However, we cannot exclude that in vivo a 
lithium-sensitive kinase, different from GSK3β is the main kinase phosphorylating 
the priming T95 site. 
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1 MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDL 
61 LTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKNVTDEQEGFAEGFVRALAE 
121 LHSQNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFSASLHSEPPVYANLSNFNPGA  
C 
 
Fig 6.8: GST-fused c-Jun constructs: A the vector used for cloning of GST fused 
mutant c-Jun constructs. B Sequence showing the mutations that were cloned. 
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C GST fused c-Jun mutants were induced by using IPTG and purified the protein 
from inclusion bodies of E.Coli cultures. Inclusion bodies were dissolved in 6M 
GuHCl, refolded the protein by dissolving it in folding buffer and dialysed the protein 
to neutralized buffer containing 15mM NaCl. Finally purified the proteins by using 
Pierce GST tagged column kit. 
 
 
 
Figure 6.9: JNK1 is able to phosphorylate T91/93 but requires intact T95 in 
vitro 
In vitro kinase assay was performed by using purified GST-c-Jun wt or GST-c-Jun-
A95 protein and incubated either with JNK1, GSK3β kinases individually or with both 
kinases together. Kinase assay were performed for 30 minutes at 30oC and stopped 
the reaction by using SDS sample buffer. The phosphorylation of GST-c-Jun 
proteins were analysed by using western blot with either pS63, pT91/93 phospho-
specific c-Jun antibodies or with total c-Jun antibody. 
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Figure 6.10: Recombinant JNK-1 phosphorylates immunoprecipitated c-Jun 
proteins at T91/93 in a T95-dependent manner 
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A NSC-34 cells were transfected with plasmids expressing either c-Jun-wt-HA or c-
JunA95-HA tagged proteins (as indicated) and levels of c-Jun site-specific 
phosphorylation were analysed by western blot of total extracts by using the 
indicated antibodies. B Either c-Jun-wt-HA or c-JunA95-HA tagged proteins were 
immunoprecipitated by using HA antibodies, then c-Jun-HA immunocomplexes were 
used as substrates for in vitro phosphorylation assays by using recombinant JNK-1, 
either alone or in combination with recombinant GSK3 β as indicated. Products of in 
vitro phosphorylation reactions were analyzed by western blot using c-Jun-phospho-
specific antibodies for p-T91/T93, p-S63 or p-239. Total amounts of c-Jun proteins 
were determined by using the c-Jun total antibody. C In vitro phosphorylation assay 
of recombinant FL-c-Jun protein (Ezio life sciences) incubated with recombinant 
JNK-1 as indicated. Reactions were analysed by western blot, using either c-Jun-
p91/93 or c-Jun-pS63 phospho-specific antibodies as indicated. Total amounts of c-
Jun proteins were determined by using the c-Jun total antibody. 
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6.2 Role of c-Jun in neuronal Inflammation 
6.2.1 LPS elicits JNK-dependent phosphorylation of c-Jun in 
bergemann glia cells 
We used DIV6 neuronal/glial cerebellar cultures established from P4 mice to 
examine c-Jun expression and activation in BG cells. This type of neuronal/glial 
culture is particularly suitable to study both physiological and inflammatory 
processes in BG cells, as they contain a large number of radial astrocytes derived 
from Bergmann glia, granule neurons and only a minor proportion of microglial cells 
(Xiong et al., 2000; Sass et al., 2001). To examine c-Jun expression in Bergmann 
glia-derived radial astrocytes, we performed double immunocytochemical staining of 
c-Jun and two Bergmann glial specific markers, the calcium binding protein S100 
and the glutamate transporter GLAST (Ullensvang et al., 1997; Hachem et al., 
2007), both expressed in the cell body and radial processes of Bergmann glia. As 
shown in figure 6.11A, nuclear c-Jun was highly expressed in both S100 and GLAST 
positive glial cells that had developed radial processes characteristic of Bergmann 
glia in vivo. Notably, immunocytochemical staining of the CD11b microglial marker 
confirmed a very low proportion of microglia in this type of cerebellar neuronal/glial 
cultures (Fig 6.11B, D). In contrast, standard cultures of microglial cells generated 
from the cortex of the same P4 mice resulted in massive staining of CD11b (Fig 
6.11C, D), validating the high immunoreactivity of the Anti-Cd11b antibody. 
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Fig 6.11: c-Jun is expressed in Bergmann glial-derived cells. A: Double 
immunostaining of DIV6 neuronal/glial cerebellar cultures generated from P4 mice 
with c-Jun (green) and S100 (red) or GLAST (red), as indicated. B: Immunostaining 
of neuronal/glial cerebellar cultures generated from P4 mice with CD11b (red). C: 
Immunostaining of cerebral microglia cultures generated from P4 mice with CD11b. 
In all described panels nuclei were stained with DAPI (blue).D: Quantifications of 
CD11b-positive cells shown in panel B and C, as indicated. Columns indicate the 
percentage of CD11b-positive cells per 103 cells. Values were plotted using a 
logarithmic scale with bars indicating SD from 3 different glass coverslips. 
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The evidence that c-Jun was highly expressed in BG cells prompted us to assess 
the effect of LPS, a potent activator of glial cells, on c-Jun phosphorylation at S63, a 
well-established hallmark of c-Jun activation (Eferl & Wagner, 2003; Karin & 
Gallagher, 2005; Raivich & Behrens, 2006). To this end, we performed double 
immunostaining of either LPS-treated or untreated neuronal/glial cultures by using 
the S100-specific antibody (Ab) together with either the c-Jun-specific Ab or the c-
Jun-pS63 Ab, which recognizes a serine phospho epitope at amino acid position 
S63 of c-Jun. We found that the number of S100/c-Jun-pS63 double positive cells 
was quite low in control cultures, but it significantly increased upon treatment with 
LPS (fig 6.12A, 6.13A). Differently, the number of S100/c-Jun double positive cells 
detected in LPS-treated culture did not change significantly compared to control 
cultures (Fig. 6.12A, 6.13A), indicating that induction of c-Jun phosphorylation is the 
initial step of c-Jun activation by LPS. As the c-Jun N-terminal kinase (JNK) is the 
major kinase mediating c-Jun activation by extracellular signals, including LPS 
(Morton et al., 2003; Ogawa et al., 2004), we then examined the effect of the JNK-
specific inhibitor SP600125 on c-Jun phosphorylation. We found that SP600125 
clearly abolished the increase of S100/c-Jun-pS63 double positive cell number 
observed in LPS-treated cultures (Fig 6.12A, 6.13A). Next, the effect of LPS on c-
Jun phosphorylation was validated by western-blot analysis (Fig 6.12B), 
demonstrating that the observed immunocytochemical variations of the c-Jun-pS63 
Ab reactivity corresponded to quantitative changes of phosphorylated c-Jun levels. 
 
Notably, LPS was unable to induce c-Jun phosphorylation in S100-negative cells, 
mostly corresponding to granule cells (GCs) (Fig 6.13B). Conversely, in these cells, 
KCl withdrawal induced c-Jun expression and phosphorylation (Fig 6.12A, 6.13A), a 
signaling response previously described in postmitotic GCs (Ma et al., 2007; Yuan et 
al., 2009). To confirm that LPS-unresponsive cells were granule neurons, we then 
performed double staining of c-Jun-pS63 and NeuroD1, a transcription factor 
expressed in postmitotic GCs (Miyata et al., 1999). We found that KCl withdrawal, 
but not LPS, induced c-Jun phosphorylation in NeuroD1-positive GCs (Fig 6.13B), 
confirming that LPS triggers c-Jun activation specifically in BG cells. 
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Fig 6.12: LPS induces JNK-dependent phosphorylation of c-Jun in radial glial 
cells. A: Double immunostaining of S100 (red) with either c-Jun (upper panels, 
green) or c-Jun-pS63 (lower panels, green) in DV6 neuronal/glial cerebellar cultures 
generated from P4 mice and treated either with vehicle (control) or with LPS 
 B: 
Western-blot analysis of DV6 cerebellar cultures described in panel A and treated 
either with vehicle (-) or with LPS (100ng/ml fo
for 2hrs), or with LPS and SP for 2 hrs, as indicated. c-Jun expression levels were 
B 
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determined by using either the c-Jun antibody or the c-Jun-pS63 antibody, as 
indicated. An antibody specific for the minichromosome maintenance complex 
component 7 protein (MCM7) was used as loading control. 
 
A 
 
B 
 
Fig 6.13: LPS does not induce c-Jun N-terminal phosphorylation in cerebellar 
granular neurons. Double immunostaining of NeuroD1(red) with either c-Jun (upper 
panels, green) or c-Jun-pS63 (lower panels, green) in DV6 cerebellar culture 
described in panel A and treated either with vehicle (control) or with LPS (100ng/ml), 
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or cultured in 5mM KCl, as indicated. B: Quantifications of c-Jun/S-100 and c-Jun-
pS63/S100 double positive cells shown in panel A. The columns indicate the 
average percentage number of double positive cells present in 10 different fields, 
with bars indicating SD 
6.2.2 Bergmann glial express TLR4 cells  
As LPS acts via Toll-like receptor (TLR) 4 (Akira et al., 2006), we than 
examined whether this receptor is expressed in Bergmann glia-derived radial 
astrocytes by performing double immunostaining for TLR4 and c-Jun. As shown in 
figure 6.14A, several c-Jun-positive Bergmann glia-derived cells showed a typical 
granular staining of TLR4 in the cytoplasm, suggesting that LPS can directly activate 
these cells. Furthermore, we show that induction of c-Jun phosphorylation by LPS 
was already detected after 20 minutes of treatment (Fig 6.14B), which is the 
minimum time required for significant induction of c-Jun phosphorylation at S63 by 
LPS in other inflammatory cells, including microglia (Hidding et al., 2002; Morton et 
al., 2003). Taken together, these results suggest that LPS directly activates (Hidding 
et al., 2002) Bergmann glia-derived radial astrocytes and in turn elicits JNK-
dependent activation of c-Jun. 
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Fig 6.14 LPS induces JNK-dependent phosphorylation of c-Jun in radial glial 
cells via TLR4. A: Double immunostaining of c-Jun (red) and TLR4 (green) in DIV6 
cerebellar cultures described in panel A. The white-boxed region delimits the 
correspondent higher-magnification images shown below. White arrowheads 
indicate examples of BG cells presenting overlapping expression for c-Jun and 
TLC4. B: Double immunostaining of S100 (red) with either c-Jun (upper panels, 
green) or c-Jun-pS63 (lower panels, green) in DV6 cerebellar cultures described in 
panel A and treated either with vehicle (control) or with LPS (100ng/ml) for 20 
minutes, as indicated. In all panels nuclei were counter stained with DAPI (blue). 
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6.2.3 c-Jun is required for Il-1beta expression in LPS-activated 
Bergmann glial cells 
 Activated glial cells release a variety of inflammatory factors, among which 
cytokines and chemokines play a crucial role in both amplification and regulation of 
the inflammatory response. We investigated whether activation of the JNK/c-Jun 
pathway by LPS induced the expression of Il-1β and ccl2, two major pro-
inflammatory molecules previously shown to be expressed n LPS-treated 
neuronal/glial cerebellar cultures (Sass et al., 2001). To this aim, we performed 
quantitative real-time PCR experiments to monitor the expression Il-1β and ccl2 in 
LPS-treated neuronal/glial cultures from P4 mice. In addition, to check whether the 
few microglial cells present in these cultures (see Fig 6.11B, D) might contribute to 
the pattern of gene expression, we examined the levels of Il-18 mRNA, a cytokine 
that is specifically induced in microglial cells by LPS, while its expression is 
constitutive in primary astrocytes (Conti et al., 1999). Our results show that LPS 
significantly induced the levels of Il-1β and ccl2 mRNAs in neuronal/glial cultures 
(Fig 6.15, 6.16A). In contrast, LPS had no effect on the constitutive levels of Il-18 
mRNA (Fig 6.16A), confirming that, in these cultures, Bergmann glia-derived radial 
astrocytes are the predominant type of glial cells contributing to the pattern of gene 
expression. Notably, the effect of LPS on Il-1β mRNAs was abolished by co-
treatment with SP600125, indicating that the JNK pathway is essential for the 
induction of Il-1β (Fig 6.16A). Differently, the increase of ccl2 mRNA was unaffected 
by SP600125 (Fig 6.16A), pointing to alternative pathways controlling ccl2 
expression. 
Next, we investigated whether LPS induced the release of Il-1β protein in the culture 
medium of neuronal/glial cerebellar cultures. As shown by ELISA analysis (Fig 
6.16B), a significant amount of Il-1β accumulated in the culture medium of LPS-
treated cultures, indicating that the increase of Il-1β mRNA by LPS correlates with 
IL-1β release. To examine the specific involvement of c-Jun in the regulation of Il-1β 
gene  expression, we next examined the levels of IL-1β mRNA in neuronal/glial 
cerebellar cultures generated from conditional knockout mice lacking c-Jun 
expression in the CNS (c-Jun-Dn mice) (Raivich et al., 2004). As shown in figure 3C, 
the large increase of IL-1β mRNA present in LPS-treated cultures from control mice 
was significantly diminished in LPS-treated cultures from c-Jun DN mice, 
demonstrating the requirement of c-Jun expression for the induction of Il-1 β, these 
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results also validate that Bergmann-derived radial astrocytes are the predominant 
glial cells expressing Il-1β in cerebellar neuronal/glial culture from P4 mice. 
 
 A 
 
    
Fig 6.15: Real time PCR Amplification curves: A: Amplification curves of real-time 
PCR analysis of Il-1β, ccl2 and IL-18 mRNAs in DIV6 neuronal/glial cerebellar 
cultures generated from P4 mice and treated either with vehicle (control) or with 
100ng/ml LPS for 12 hrs (Le et al.), or with LPS and 5mM SP600125 (SP), as 
indicated in the histogram legend. The data were normalized to Gapdh mRNA and 
represented as fold change relative to RNA levels in not treated cultures. 
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Fig 6.16: The JNK/c-Jun pathway is essential for the induction of IL-1β mRNA. 
A: Quantitative real-time PCR analysis of Il-1β, ccl2 and IL-18 mRNAs in DV6 
neuronal/glial cerebellar cultures generated from P4 mice and treated either with 
vehicle (control) or with 100ng/ml LPS for 12 hrs (Le et al.), or with LPS and 5mM 
SP600125 (SP), as indicated in the histogram legend. The data were normalized to 
Gapdh mRNA and represented as fold change relative to RNA levels in not treated 
cultures, which were set to 1. Values were plotted using a logarithmic scale. Error 
bars represent SD of three independent experiments. B: IL-1β detection by ELISA in 
the supernatants collected from DIV6 cerebellar cultures described in panel A and 
treated either with vehicle (cont) or with 100ng/ml LPS for 24 hrs (Le et al.) as 
indicated. Columns represent levels of IL-1β levels in pg/ml with bars indicating SD 
from 3 parallel experiments. C: Quantitative real-time PCR analysis of Il-1β and ccl2 
mRNAs from DIV6 neuronal/glial cerebellar cultures generated from either P4 c-Jun 
fl/fl mice or P4 c-Jun-Dn mice and treated with vehicle (control) or with 100ng/ml 
LPS for 12 hrs (Le et al.) as indicated in the histogram legend. The data were 
normalized as described in panel A. Scale Error bars represents SD of three 
independent experiments. 
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6.2.4 c-Jun is expressed during formation of the Bergman glial 
monolayer 
 To substantiate the relevance of astroglial expression of c-Jun in 
neuronal/glial cerebellar cultures, we then examined the cell-type and layer-
distribution of c-Jun-expressing cells in the early postnatal cerebellum. To this end, 
mouse cerebellar sections from P1, P4 and P7 mice were double immunostained 
with c-Jun and two BG specific markers, S100 and GLAST. Confocal microscopy 
analyses of P1 and P4 cerebellar sections showed that the majority of c-Jun-positive 
cells were concentrated underneath and surrounding Purkinje cells (PCL), hence 
forming a cellular layer encompassing the territory of BG cells (Fig 6.17A, B, D). 
Furthermore, within the BG layer, several nuclei of either S100- or GLAST-positive 
cells were immunostained by the c-Jun Ab (Fig 6.17A, B, C), indicating c-Jun 
expression during formation of the BG monolayer. In contrast, at P7, c-Jun positive 
cells were mainly distributed in the IGL and only few cells were double positive for c-
Jun and S100 (Fig 6.17C), revealing a developmental stage-specific expression of 
Jun in BG cells.  
To validate c-Jun expression in BG cells, we examined the mitotic activity of c-Jun-
positive in P1 mice, as BG cells have been described to be highly proliferative at this 
developmental stage (Yuasa, 1996). To this end, we performed BrdU pulse-labelling 
in P1 mice and analysed cerebellar sections by double-immunostaining with c-Jun 
and BrdU. As shown in figure 6.17E, several cells were c-Jun/BrdU double positive 
and primarily located in the BG layer, confirming c-Jun expression in proliferating 
cells of the BG layer. 
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Fig 6.17: c-Jun is expressed in Bergmann glial cells. A-C: Double 
immunostaining of c-Jun (green) and S-100 (red) on sections of P1 (A), P4 (B) and 
P7 (C) mouse cerebella, as indicated. Nuclei were counter stained with DAPI (blue). 
White-boxed regions in P1 and P4 delimit the correspondent higher-magnification 
images shown alongside. Double immunostaining of c-Jun (green) and GLAST (red) 
on sections of in P1 mad P4 mouse cerebella, as indicated. E: Double 
immunostaining of coronal sections of P1 cerebella showing either c-Jun (green) or 
BrdU (red) positive cells, as indicated. Overlapping staining (orange) for c-Jun and 
BrdU are merged in the left panel, as indicated. White arrowheads indicate 
examples of BG cells presenting overlapping expression for c-Jun and each of the 
indicated markers. 
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6.2.5 c-Jun expression in Purkinje cells and granule neurons 
 To investigate the cellular identity of c-Jun-positive cells not expressing BG 
markers, we performed double immunostaining of c-Jun and a set of cell-type 
specific markers in cerebellar sections from P1, P4 and P7 mice. Firstly, we carried 
out double staining for c-Jun and calbindin, a specific marker for Purkinje cells (PCs) 
(Celio, 1990). Sections from P1 and P7 cerebella showed lack of c-Jun expression in 
PCs (Fig 6.18A). However, at P4, few cells were reproducibly double positive for c-
Jun and calbindin, revealing that c-Jun can be expressed in Purkinje neurons during 
a narrow developmental window. 
 
Next, we examined the co-expression pattern of c-Jun and markers of NeuN, a 
transcription factor widely used to mark post-mitotic neurons and expressed in 
differentiated GCs (Weyer & Schilling, 2003). As shown in Fig 6.18B, c-Jun/NeuN 
double-positive cells were detected in the IGL of all three developmental stages. In 
contrast, NeuN was not expressed in c-Jun-positive cells located in the BG layer, 
confirming that these cells are mostly BG cells. Same results were obtained by 
double staining of c-Jun and NeuroD1 (Fig 6.18C), validating c-Jun expression in 
postmitotic GC of the IGL. We also examined the co-expression pattern of c-Jun and 
Pax6, a transcription factor that is expressed in postmitotic GC precursors and 
throughout the course of their migration and differentiation (Yamasaki et al., 2001). 
As shown in Fig 6.18D, at all examined stages, c-Jun was expressed in Pax6-
positive located in the IGL. Furthermore, at the P4 stage, several Pax6/c-Jun 
double-positive cells encompassed the BG layer (Fig 6.18D), presumably 
representing post-migratory GC precursors at the onset of differentiation. 
 
c-Jun expression was then examined in GABAergic interneurons by performing 
double immunostaining of c-Jun and Pax2, a transcription factor expressed in 
GABAergic interneurons of the developing cerebellum (Maricich & Herrup, 1999). As 
shown in figure 6.19, most of Pax-2 positive neurons were negative for c-Jun 
expression, with only few cells presenting overlapping expression of c-Jun and 
Pax2. Finally, we investigate the pattern of c-Jun N-terminal phosphorylation on S63. 
To this end, we performed immunostaining of cerebellar sections with the c-Jun-
pS63 Ab. Several c-Jun-pS63 positive cells were detected in the IGL throughout the 
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P1-P7 stages (Fig 6.18E) and resulted mostly positive to NeuN and NeuroD1 (Fig 
6.20). In contrast, c-Jun-pS63 positive cells were very rarely detected in the BG 
layer (Fig 6.18E, Fig 6.20), suggesting that developmentally regulated signaling 
modulate c-Jun activation in a cell-type specific fashion. Taken together these 
observations indicate that, in the early postnatal cerebellum, neuronal expression of 
c-Jun is mainly restricted to the IGL, where it is present in post-migratory GC 
precursors at the onset of their differentiation and continues during their terminal 
differentiation. 
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Fig 6.18: Dynamic distribution of c-Jun positive cells in the early postnatal 
cerebellum.  A: Double immunostaining of c-Jun (green) and calbindin (red) on 
sections of P1, P4 and P7 mouse cerebella, as indicated. Purkinje cell 
immunostaining by anti-calbindin clearly distinguishes the forming PCL. At P1 and 
P4 , c-Jun immunostaining  shapes a cellular layer underneath the PCL. White 
arrowheads indicate Purkinje cells presenting overlapping expression for calbindin 
and c-Jun at P4. B-D: Double immunostaining of c-Jun (green) and NeuN (B), or 
NeuroD1 (C) or Pax6 (D) on of sections of P1, P4 and P7 mouse cerebella, as 
indicated. White arrowheads indicate examples of neuronal cells presenting 
overlapping expression for c-Jun and each of the indicated markers. E: 
Immunostaining of c-Jun-pS63 (green) on tissue sections of P1, P4 and P7 mouse 
cerebella, as indicated. In all panels nuclei were stained with DAPI (blue). EGL, 
external granular layer; PLC, Purkinje cell layer; IGL internal granular layer. 
 
Fig 6.19: c-Jun expression in inhibitory interneurons. A-B: Double immuno 
staining of sections from P1 (A) or P4 (B) cerebella showing either c-Jun (green) or 
Pax2 (red) positive cells, as indicated. Overlapping staining (orange) for c-Jun and 
Pax2 are merged in the left panel, as indicated. Nuclei were counter stained with 
DAPI (blue). White arrowheads indicate examples of neuronal cells presenting 
overlapping expression for c-Jun and Pax2. EGL, external granular layer; PLC, 
Purkinje cell layer; IGL internal granular layer; WM, white matter. 
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Fig 6.20: c-Jun N-terminal phosphorylation in granule cells. A-B: Double 
immunostaining on sections of P4 cerebella with the c-Jun-pS63 antibody (green) in 
combination with either (A) NeuN antibody (red) or (B) NeuroD1 antibody (red), as 
indicated. Overlapping staining (orange) are merged in the left panel, as indicated. 
 
 
 
 
Discussion 
114 
7 Discussion  
Gene expression by the JNK/c-Jun pathway is involved in very different cellular 
programs, including cell cycle progression, differentiation and apoptosis. In turn, 
deregulation of the JNKs/c-Jun pathway may give rise to pathological conditions, 
including tumor progression, neuroinflammation and degenerative loss of neurons 
(Waetzig & Herdegen, 2004; Vinciguerra et al., 2008). The challenging question is 
how the same signaling pathway can regulate the expression of genes involved in 
quite different cellular programs. One possible mechanism underlying the functional 
dicothomy of c-Jun/Ap-1 may be based on the type of c-Jun partner forming the 
dimeric Ap-1 transcription factor, which in turn might determine the class of activated 
target genes (Hess et al., 2004; Yuan et al., 2009). On the other side, the kinetic of 
the JNK/c-Jun signaling pathway is ceartainly involved in determining the diverse 
outputs of c-Jun biological activity. Several studies have shown that depending on 
the kinetic of JNK activation, variations in c-Jun levels and activation periods are 
coupled to different patterns of gene expression (Raman et al., 0000; Ventura et al., 
2006; Comalada et al., 2012). Our results suggest that depending on the complexity 
of external signals and their interplay with intrinsic cues, c-Jun phosphorylation by 
JNK may result differential at a site-specific level and in turn elicit different 
physiological responses. 
7.1 Differential phosphorylation of N-terminal c-Jun in neuronal 
cells 
Based on our results, we propose that depending on the complexity of external 
signals and their interplay with intrinsic cues, c-Jun phosphorylation by JNK may 
result differential at a site-specific level and in turn elicit different physiological 
responses. In particular, we provide evidence that in cerebellar granule cells, 
apoptotic cues lead to extensive phosphorylation of c-Jun N-terminal domain, with 
T91/T93 phosphorylation setting the threshold for c-Jun pro-apoptotic activity. In 
contrast, a concomitant activation of survival pathways initiated by lithium inhibits 
T91T93 phosphorylation with no effects on S63 phosphorylation, hence preventing 
the onset of c-Jun pro-apoptotic activity without interfering with possible non-
destructive functions of c-Jun requiring S63 phosphorylation. 
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Two lines of evidence indicate that T91/T93 phosphorylation results in a threshold 
for c-Jun pro-apoptotic activity. The first evidence addresses the type of response of 
T91/T93 phosphorylation to apoptotic clues and comes from immunofluorescence 
analysis of c-Jun site-specific phosphorylation. This analysis shows that the 
response of T91/T93 phosphorylation to TK-deprivation is not graded but rather 
sensitive and mirrors the switch-like apoptotic response of TK-deprived neurons. 
The second evidence addresses the functional role of T91/T93 phosphorylation in 
triggering c-Jun pro-apoptotic activity and comes from the functional analysis of the 
c-JunA95 mutant in CGC apoptosis. This analysis shows c-JunA95-mutated proteins 
are not phosphorylated at T91/T93 in response to TK-deprivation and failed to 
promote CGC apoptosis. These findings confirm that in absence of T91/T93 
phosphorylation, S63-phopshorylated c-Jun is not able to promote cell death. Also, 
they corroborate the regulatory role of the T95 site in priming T91/T93 
phosphorylation by JNK. Furthermore, the finding that c-JunA95 is fully capable to 
induce neurite outgrowth in naïve PC12 cells validates that lack of T91/T93/T95 
phosphorylation does not interferes with regenerative functions of c-Jun. However, 
whether such a functional role of c-Jun phosphorylation is a general principle, or 
applies to specific neuron populations, needs to be explored in future studies. 
 
A further important question addressed by our study is the mechanism through 
which lithium blocks c-Jun pro-apoptotic function without inhibiting JNK activity. The 
specific effect of lithium on T91/T93 phosphorylation, together with the evidence that 
the c-JunD95 mutant resumes GCG apoptosis in presence of lithium is consistent 
with a model whereby lithium blocks c-Jun pro-apoptotic activity by targeting the 
priming T95 phosphorylation event for T91/T93 phosphorylation. In such a scenario, 
the priming event for T91/T93 phosphorylation acquires a crucial role in determining 
the output of c-Jun biological activity in response to JNK activation. 
 
Lithium is a widely used drug for treatment of mood disorders, and yet the 
mechanism of action of lithium in neuronal disorders is unclear (Lenox RH, 2000). 
Interestingly, in a number of neurodegenerative disease models, both GSK-3 and 
JNK have been linked to pathogenic mechanisms. For example, both JNK and GSK-
3 are implicated in Alzheimer’s disease (MIGHELI et al., 1997; Thakur et al., 2007). 
In the study by Marcus and collaborators, it was shown that cortical neurons lacking 
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JNK3 expression, or cells expressing dominant-negative c-Jun mutant proteins, are 
protected from Beta amyloid aggregates (a key player in Alzheimer’s pathogenesis). 
Furthermore, elevated JNK activity and c-Jun protein levels were detected in post-
mortem brains of Alzheimer’s patients (Marcus et al., 1998; Shoji et al., 2000; Zhu et 
al., 2001). Similarly, GSK-3 activity was also shown to be elevated in post-mortem 
brains of Alzheimer’s patients and induced by B-amyloid peptides in  cultured 
hippocampal neurons (Takashima et al., 1998; PEI et al., 1999). Therefore, it would 
be of interest to examine the frequency of such tandem regulation of JNK and GSK-
3 in diverse models of neurodegenerative diseases. 
7.2 In vivo and In vitro phosphorylation of c-Jun at T95-T93-T91 
Previous studies by Vinciguerra and colleagues have clearly shown that 
alanine substitution of T95 strongly impairs the induction of T91/93 phosphorylation 
of c-Jun by genotoxic stress (Vinciguerra et al., 2008), suggesting that T95 acts as a 
phosphoacceptor site priming T91/T93 phosphorylation. However, till now T95 
phosphorylation in cells was not addressed. In the present study, we performed 
mass-spectrometry analysis demonstrating that c-Jun is phosphorylated in cells at 
tall three T91/T93/T95 sites. As regard the mechanism through which lithium control 
the levels of T93/T93, our results could not establish whether lithium inhibits a 
kinase phosphorylating the T95 priming site, or by inducing a phosphatase removing 
T95 phosphorylation. However, our experiments show that recombinant JNK-1 fully 
phosphorylates c-Jun in vitro at the T91/T93 sites in a T95-dependent manner. 
These results suggest that in CGCs JNK sequentially phosphorylates c-Jun at T95-
T93-T91 in response to TK-deprivation, whereas lithium may induce a T95-specific 
phosphatase. Although the T95 site does not contain the minimal S/TP sequence for 
MAP kinases, it has been previously shown that both JNK-2 and JNK-1 can 
phosphorylate a similar site in histone H2AX (Lu et al., 2006; Sluss & Davis, 2006). 
Future experiments will elucidate whether in vivo T95 is phosphorylated by JNKs or 
by a lithium-sensitive kinase. Alternatively, lithium might inhibit T95 phosphorylation 
by regulating nuclear translocation of JNKs, hence limiting the local concentration of 
active JNKs necessary to phosphorylate the non-canonical T95 site. Accordingly, 
inhibition of JNK2-3 nuclear translocation has been described to protect from 
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neuronal apoptosis in sympathetic neurons and CGCs (Sengupta Ghosh et al., 
2011; Benny et al., 2012). 
In conclusion, Our results provide the first evidence that in the CGCs apoptotic and 
survival cues give rises to different site-specific configurations of c-Jun N-terminal 
phosphorylation, each of which having different functional outputs. Furthermore, our 
study suggests that inhibition of T91/T93/T95 phosphorylation may represent a 
pharmacological tool to selectively target c-Jun-dependent degenerative pathways 
in the nervous system. 
7.3 Role of c-Jun in LPS-mediated activation of Bergmann Glial 
cells 
We have used neuronal/glial mouse cerebellar cultures generated from P4 
mice neonatal mice to assess putative functions of c-Jun in activated Bergmann glial 
cells. By using BG glial specific markers and granule neurons expressing postmitotic 
neuronal markers we show that these neuronal/glial cerebellar cultures contain 
mainly two types of cells: radial glial cells and granule neurons. To check the 
microglia population in these cultures we have used CD11 as a marker and 
confirmed that on an average of 1% population stained with the microglia marker, 
indicating that these cultures are adequate to dissect inflammatory pathways specific 
of BG-derived cells. 
 
Firstly, from immunohistochemical staining we confirmed that c-Jun is highly 
expressed in the nucleus of radial astrocytes derived from Bergmann glia, also we 
show that Jun-positive cells coexpressed with BG specific markers in their soma and 
uni/bipolar processes, a characteristic of BG cells in vivo. Secondly, we show that 
upon addition of bacterial LPS triggers activation of the JNK/c-Jun pathway in BG 
cells, as indicated by a robust JNK-dependent phosphorylation of c-Jun on S63. 
Notably, induction of c-Jun phosphorylation by LPS was specifically detected in BG-
derived astrocytes and abrogated by pharmacological inhibition of JNK, suggesting a 
functional role of the JNK/c-Jun pathway in the activation of Bergmann glial cells. 
LPS has been widely shown to activate inflammatory cells via TLR4 (Akira et al., 
2006). Within the CNS, TLR4 is predominantly expressed by microglia, however its 
expression has been also reported in astrocytes (Forshammar et al.; Gorina et al.; 
Bowman et al., 2003; Sun et al., 2008), suggesting that LPS can directly activate 
Bergman glia-derived cells and in turn induce c-Jun activation. Accordingly, we 
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observed a significant expression of TLR4 in c-Jun-positive Bergman glia-derived 
astrocytes. Moreover, we show that the induction of Jun phosphorylation by LPS is 
as rapid as in microglia or macrophages (Hidding et al., 2002; Morton et al., 2003), 
making unlikely an indirect effect of LPS (mediated by microglia) on Bergman glia-
derived cells. 
7.4 c-Jun is required for LPS-induced expression of Il-1β 
 We confirmed the involvement of the JNK/c-Jun pathway in the activation of 
BG-derived cells by showing that LPS induced IL-1β gene expression and 
pharmacological inhibition of JNK activity abolished both c-Jun phosphorylation and 
the increase of IL-1β mRNA. Most importantly, our results demonstrate an essential 
role of c-Jun in mediating activation of Bergmann glial cells, as the increase of IL-1β 
mRNA by LPS was abolished in neuronal/glial cultures from the c.Jun-Dn mutant 
mice, lacking c-Jun expression specifically in the CNS. In addition, this observation 
corroborates that Bergmann glia-derived cells are the predominant cell type 
contributing to the induction of Il-1β in the neuronal/glial cultures used in the present 
study, given that c-Jun is normally expressed in microglial cells from c-Jun-Dn 
mice(Raivich et al., 2004). 
 
Whether c-Jun is directly involved in the activation of the IL-1β gene in cerebellar 
astroglial cells remains to be elucidated. However, previous observations have 
shown the requirement of AP-1 activity for activation of the IL-1β promoter in 
macrophages (Kang et al., 2004), suggesting a direct contribution of c-Jun to the 
regulation of IL-1β gene expression. 
7.5 In vivo expression of c-Jun in the postnatal cerebellum 
The finding that c-Jun is expressed in Bergmann glia-derived radial glial cells 
was confirmed and extended in vivo by immunohistochemical analyses of the early 
postnatal cerebellum. We found high levels of c-Jun expression in the nuclei of 
S100- and GLAST-positive cells, both in P1 and P4 mice. Besides, c-Jun positive 
cells defined a cellular layer underneath the PCL and were mitotically active, two 
characteristics of BG cells at this developmental stages (Yuasa, 1996). In addition, 
the significant loss of c-Jun staining in the BG monolayer of P7 mice suggests a 
developmental stage-specific expression of c-Jun, corresponding to the formation of 
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the BG monolayer. As previously described (Carulli et al., 2002), we found c-Jun 
expression in postmitotic differentiated GC of the IGL, as proved by the large 
number of c-Jun/NeuN and c-Jun/NeuroD1 double positive cells. In addition, our 
results reveal c-Jun expression in post-migratory GC precursors, as proved by the 
presence of c-Jun/Pax6 double positive cells both across the PCL and in the IGL. 
We currently have no hints on the possible function of c-Jun expression during the 
formation of the BG monolayer. c-Jun has been shown to be crucial for cell cycle 
progression of several type of cells, suggesting that it may be important for BG cell 
proliferation. However, this hypothesis is not supported by our results showing that 
c-Jun phosphorylation on S63, a critical requirement for c-Jun proliferative function 
(Shaulian E, 2001 Apr 30; Wada et al., 2004; Wada & Penninger, 2004), was 
exclusively detected in postmitotic GCs of the IGL. Moreover, our preliminary 
analyses of either P4 or P14 c-Jun Dn mice indicate no significant anomaly in the 
number or localization of BG cells (LA and AMM, unpublished observations). 
  
On the other hand, the evidence that c-Jun is essential for the induction of IL-1β 
expression in vitro activated BG cells, together with the evidence that it is highly 
expressed during formation of the BG monolayer, points to a putative role of c-Jun in 
neuroinflammatory responses of the neonatal cerebellum. IL-1β, besides being the 
major cytokine induced by acute brain injury (Patel et al., 2003), plays an important 
role in kainite-induced cerebellar ataxia  (Andoh et al., 2008), suggesting that 
signaling pathways controlling its expression may participate to the pathogenesis of 
sporadic cerebellar ataxia. Future experiments in mouse models of 
neuroinflammatory diseases or sporadic cerebellar ataxia will then establish the role 
of c-Jun in astroglia-mediated dysfunction of the cerebellum. 
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